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As no successful therapeutic approach to treat Alzheimer’s disease (AD) has been 
developed to date, preventative strategies and non-pharmacological interventions 
increasingly become a major research focus. In recent years, substantial evidence for a 
protective role of physical and cognitive activity on the risk of AD has been growing. In 
the present study, the effect of a challenging environment in combination with regular 
exercise on the Alzheimer-like pathology of the Tg4-42 and 5XFAD mouse models was 
investigated.  
The Tg4-42 model overexpresses N-truncated Aβ4-42 without any mutations and 
develops an age- and dose-dependent neuron loss in the CA1 region of the 
hippocampus associated with a severe memory decline. It could be shown that long-
term cognitive and physical stimulation significantly delay hippocampal neuron loss 
and completely rescue memory deficits in 12-month-old Tg4-42 mice. Moreover, long-
term gene expression profile changes yielding to neuroprotective events could be 
observed in enriched housed Tg4-42 mice. These effects were irrespective of brain Aβ4-
42 levels and increased neurogenesis rates. The present findings provide evidence for 
the first time that neuron loss and memory decline can be counteracted by prolonged 
physical and cognitive activity in a mouse model that rather reflects the sporadic form 
of AD. 
The 5XFAD model is a well-characterized, commonly used AD model for the familial 
form of the disease, representing an early and aggressive pathology. In the present 
work, it could be demonstrated that prolonged cognitive and physical activity has no 
therapeutic benefit on the pathophysiology of this conventional 5XFAD model. Despite 
partial improvements in motor performance, no beneficial effects in terms of 
behavioural deficits, Aβ plaque deposition, Aβ1-42 levels or inflammatory phenotype 
were observed. These results suggest that a rather mild intervention like mental 
stimulation and regular exercise cannot counteract the aggressive AD pathology seen 
in 5XFAD mice.  
In sporadic AD cases, a decelerated degradation of Aβ is supposed to be the primary 
cause of an enhanced accumulation of the peptide in the brain. Neprilysin (NEP) 




studies and hence is assumed to play a pivotal role in the progression of AD. In order 
to gain deeper knowledge about the function of NEP, 5XFAD mice were crossed with 
homozygous NEP knock-out mice. NEP reduction led to an impaired spatial working 
memory performance in 6-month-old 5XFAD mice. Furthermore, depletion of the 
enzyme increased extracellular amyloid deposition in specific brain regions and 
enhanced the inflammatory response in the brain. In young 5XFAD mice, however, NEP 
knock-out led to a delayed Aβ plaque deposition accompanied by elevated levels of the 
NEP homologue endothelin-converting enzyme 1 (ECE1). These data support previous 
observations showing that NEP is a substantial Aβ-degrading enzyme and suggest a 
reciprocal effect between NEP and ECE1 activities in young 5XFAD mice.  
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1.1 Alzheimer’s disease 
Alzheimer’s disease (AD) is an irreversible, progressive brain disorder representing 
the most common cause of dementia in the elderly population (Barker et al., 2002). 
According to the Alzheimer’s association report, AD is the sixth-leading cause of natural 
death in the United States and evolved to be an enormous public health problem 
(Alzheimers Association, 2015). For those aged 65 and older, the risk to develop AD 
doubles every five years (Querfurth and LaFerla, 2010). Currently, there are 
approximately 1.5 million people suffering from dementia in Germany, with two-thirds 
of them being diagnosed with AD. This number is estimated to increase up to 3.0 
million by 2050 due to the demographic development (Bickel, 2012).  
1.2 Clinical features of Alzheimer’s disease 
The course of AD is slowly progressive and can be separated in different stages. Before 
clinical symptoms become apparent, neurodegenerative processes in the brain start 
and accumulate. This time period is referred to as preclinical AD and can last several 
years (Backman et al., 2004). When neurodegeneration reaches a certain level, 
neuropsychological tests can reveal the stage of mild cognitive impairment (MCI). In 
this stage, a person still lives independently but learning and memory abilities start to 
decline. Patients tend to forget recent events and appointments and develop difficulties 
in performing tasks in work and social settings. In the moderate stage of AD, patients 
require supervision as they develop impairments of language, motor deficits, 
disorientation and strong memory decline. Furthermore, personality and behavioural 
changes such as aggression, suspiciousness and delusions develop (Forstl and Kurz, 
1999). In the late stage of AD, patients lose the ability to interact with their 
environment and require full-time assistance. Next to extreme lethargy and apathy, 
language skills are minimized and motor impairments, including rigidity, poor posture 
and bradykinesia become apparent (Scarmeas et al., 2004). Ultimately, patients lose 
their ability to swallow and become prone to infections like pneumonia (Frank, 




1.3 Neuropathological hallmarks 
1.3.1 Amyloid deposits 
The extracellular deposition of amyloid beta (Aβ) in form of plaques represents one of 
the major hallmarks of AD. Based on their morphology, senile amyloid plaques can be 
categorized in either neuritic or diffuse plaques (Yamaguchi et al., 1988;Small, 1998) 
(Figure 1). Neuritic plaques, or dense-core plaques, are composed of highly aggregated 
filamentous Aβ surrounded by dystrophic neurites, micro- and astrogliosis (Selkoe, 
2001;Duyckaerts et al., 2009). These plaques can be detected with β-sheet binding dyes 
like Thioflavin S and Congo Red and range in size from 10 to 120 µm. Being primarily 
formed in the neocortex, neuritic plaques later spread to the hippocampus, amygdala, 
subcortical layers and brain stem (Arnold et al., 1991;Thal et al., 2002). In contrast, 
diffuse plaques are not detectable with β-sheet binding dyes as they consist of 
amorphous, less aggregated Aβ depositions. They vary in size from 50 µm to several 
hundred µm and they are suggested to be precursors for neuritic plaques (Yamaguchi 
et al., 1988;Dickson, 1997). Intriguingly, diffuse plaques are not only detectable in AD 
patients, but also in cognitively normal, healthy individuals (Morris et al., 1996).    
 
 
Figure 1: Amyloid plaques. Neuritic plaques (A) and diffuse amyloid plaques (B) visualized by 
immunohistochemistry. 
1.3.2 Neurofibrillary tangles 
Neurofibrillary tangles (NFTs) represent another major histopathological hallmark of 
AD (Alzheimer, 1907). These intracellular aggregates are present in the perikarya or 





a helical structure. PHFs are composed of hyperphosphorylated, microtubule-
associated tau (MAPT) (Kidd, 1963). Tau, under physiological conditions, supports the 
assembly of microtubules and therefore stabilizes the cytoskeleton (Drechsel et al., 
1992). However, upon phosphorylation by diverse kinases, tau dissociates from the 
microtubules and aggregates into NFTs. Hyperphosphorylated tau aggregates cause 
diverse cellular dysfunctions including protein mistrafficking and loss of neuronal 
integrity (Ittner and Gotz, 2011). Unlike amyloid pathology, the localization of NFTs 
correlates well with the severity of AD progression. Therefore, tau pathology is used to 
stage the severity of AD into the Braak stages I-VI (Braak and Braak, 1991;Braak et al., 
2006).   
1.3.3 Brain atrophy 
Next to amyloid plaques and NFTs, brain atrophy represents one of the most prominent 
pathological features of AD (Figure 2). This atrophy is caused by neuron loss in a region 
specific manner and is characterized by enlarged ventricles, widening of cortical sulci 
and shrinkage of gyri. Using magnetic resonance imaging (MRI), brain volume and 
weight reductions can be detected even at early stages of disease progression and are 
therefore predictable for the progression from MCI to AD (Jack et al., 2005). Atrophy is 
predominantly affecting the medial temporal lobe including the hippocampus, 
amygdala and entorhinal cortex (Bottino et al., 2002). The underlying cause of neuron 
death is still not known in great detail. Very early studies suggested a correlation 
between NFTs and neuron loss (Cras et al., 1995). Other findings reported evidence for 
apoptosis as one of the mechanisms contributing to cell death in AD (Shimohama, 
2000). However, more recent studies link the neurotoxicity of intraneuronal and/or 
oligomeric Aβ with cell death (Bayer and Wirths, 2010).  
In addition to neuron death, loss of synapses contributes to the cortical atrophy in AD 
brains. Synaptic loss is supposed to be an early pathological alteration that precedes 
neuron death (Serrano-Pozo et al., 2011). Accordingly, patients with mild AD display 
significantly fewer synapses in the cornu ammonis area 1 (CA1) region of the 
hippocampus when compared to healthy controls or patients with MCI (Scheff et al., 
2007). The loss of synapses represents the structural correlate to early cognitive 
decline as supported by the fact that synaptic counts significantly correlate with the 






Figure 2: Brain atrophy in AD. Compared to the control subject (left), a patient with AD (right) shows 
enlargement of ventricles, widening of sulci and shrinkage of gyri. Tissue loss is specifically evident in 
the hippocampal region and entorhinal cortex. Modified from http://www.alz.org/braintour.asp. 
1.3.4 Inflammation 
Neuroinflammation represents an additional pathological hallmark of AD. 
Inflammatory processes are consistently found in brains of AD patients and also occur 
in transgenic AD mouse models (Hoozemans et al., 2006;Schwab et al., 2010). As astro- 
and microgliosis are predominantly present in close proximity of neuritic plaques, it is 
suggested that Aβ promotes the inflammatory profile (Itagaki et al., 1989). Activated 
astrocytes (Figure 3) and microglia release proinflammatory as well as potentially 
neurotoxic substances such as cytokines, complement factors, reactive oxygen 
intermediates and chemokines. However, activated microglia have also been shown to 
phagocytose Aβ deposits and remove soluble forms of Aβ, therefore exerting a 
neuroprotective role (Mandrekar-Colucci and Landreth, 2010). Moreover, activated 
astrocytes can internalize and degrade Aβ42 deposits (Wyss-Coray et al., 2003). In 
support of this, it is still controversy whether inflammatory processes are causative for 
AD or if it is a protective reaction in response to Aβ toxicity (Wyss-Coray and Rogers, 













Figure 3: Inflammatory response in AD. Confocal image of activated astrocytes in 5XFAD mice. A 
neuritic plaque (green) is surrounded by activated astrocytes (red). 
1.4 The amyloid precursor protein 
The amyloid precursor protein (APP) is a ubiquitously expressed, type I integral 
membrane protein that is encoded by a gene located on chromosome 21 (Yoshikai et 
al., 1990). APP is part of a large evolutionary conserved gene family with two 
mammalian homologs, APLP1 and APLP2 (Wasco et al., 1992). These proteins display 
a high degree of homology in extracellular domains and intracellular C-terminal 
portions, but the Aβ containing trans- and juxtamembrane domains are unique to APP 
(Bayer et al., 1999).  Through alternative splicing, different isoforms of APP are being 
generated. While APP695 is primarily expressed in neurons, longer isoforms like 
APP751 and APP770 are also being expressed in other tissues and cell types (Mattson, 
1997). In the endoplasmatic reticulum (ER) and Golgi networks, immature APP 
undergoes posttranslational modifications before it is transported and integrated to 
the plasma membrane (Weidemann et al., 1989). During development, APP expression 
is found at growth cones of developing neurites, while in mature neurons, the protein 
is localized within pre- and postsynaptic structures and at focal adhesion sites 
(Yamazaki et al., 1997;Sabo et al., 2003). Although the precise physiological role of 
uncleaved APP remains unclear, the protein has been implicated in processes such as 
synapse formation (Priller et al., 2006), cell growth (Saitoh et al., 1989), neurite 




1.4.1 Amyloidogenic and non-amyloidogenic processing of APP 
APP is physiologically processed in two alternative pathways, which constantly 
compete with each other (Figure 4). In the non-amyloidogenic pathway, α-secretases 
cleave APP within the Aβ domain, thereby preventing its generation. Numerous 
members of the “a disintegrin and metalloprotease” (ADAM) family can function as α-
secretases with ADAM10 being the physiologically most relevant, constitutive 
secretase in neurons (Kuhn et al., 2010). The ADAM10 cleavage induces the release of 
the soluble sAPPα fragment into the lumen/extracellular space (Sisodia, 1992). The 
remaining C-terminal fragment (C83) is subsequently cleaved by γ-secretase which 
liberates the soluble fragment p3 and the APP intracellular domain (AICD) (Zheng and 
Koo, 2011). The p3 fragment is rapidly degraded while the physiological role of AICD 
remains unclear. Controversial studies have implicated AICD in the regulation of gene 
transcription (Haass et al., 1993).  
In the amyloidogenic pathway, Aβ is produced by the consecutive action of β- and γ-
secretase. β-site APP cleavage enzyme 1 (BACE1) releases a large part of the 
ectodomain of APP (sAPPβ) and generates the membrane-bound APP C-terminal 
fragment C99 (Vassar et al., 1999). C99 is subsequently cleaved by the y-secretase 
protein complex at various cleavage sites, resulting in the liberation of Aβ peptides and 
AICD (Annaert and De Strooper, 2002). As the final γ-secretase cleavage is not precise, 
generated Aβ peptides can range from 37 to 43 amino acids in length, with Aβ1-40 being 
the most common isoform under physiological conditions (Haass et al., 1992;Citron et 
al., 1995). The γ-secretase protease complex consists of four trans-membranous 
subunits: presinilin (PSEN) 1 or PSEN2, nicastrin (NCT), anterior pharynx defective 
(APH)-1a or APH-1b and the PSEN enhancer (PEN)-2. While PSEN1/2 contain the 
catalytic active domain for APP cleavage, little is known about the biological function 





Figure 4: APP processing pathways. During the non-amyloidogenic pathway (left), APP is sequentially 
cleaved by α- and γ-secretase, resulting in the release of p3 and AICD. The Aβ-liberating amyloidogenic 
way (right) is initiated by a BACE1 cleavage of APP. Subsequently, the γ-secretase complex induces the 
release of Aβ and AICD. Adapted from (Haass et al., 2012).  
1.5 The amyloid hypothesis 
The amyloid cascade hypothesis (Figure 5) was first described by Hardy and Allsop in 
1991 and is based on the idea that Aβ has a central role in the pathological cascade of 
AD (Hardy and Allsop, 1991). The hypothesis states that an increase of extracellular Aβ 
levels is the causative event of AD pathology leading to the formation of NFTs, neuron 
and synapse loss, vascular damage, memory loss and other clinical AD symptoms. 
Numerous observations support the classical amyloid cascade hypothesis. For 
example, mutations in APP and PS increase the production of Aβ thereby leading to the 
familial form of AD (FAD) (Rademakers and Rovelet-Lecrux, 2009). Furthermore, 
transgenic rodent models that express mutations linked to FAD recapitulate numerous 
aspects of AD pathology including Aβ plaque deposition, gliosis and memory deficits 
(Duyckaerts et al., 2008). In addition, Down-Syndrome patients harbour a triplication 
of the APP gene on chromosome 21 which ultimately leads to AD pathology formation 
at young ages (Wisniewski et al., 1985). However, over time, some major controversies 
against the classical amyloid hypothesis have evolved. First of all, studies in humans 
and AD mouse models revealed that plaque load does not correlate consistently with 
the severity of cognitive decline (Snowdon, 2003;Walsh and Selkoe, 2007). 
Accordingly, cognitively normal individuals who do not show any signs of dementia 




















mouse models develop cognitive deficits and neuropathological changes before 
showing extracellular plaques (Walsh and Selkoe, 2007;Lesne et al., 2008).  
In consideration of these observations, a modified amyloid hypothesis has been 
proposed. The revised version emphasizes intraneuronal Aβ accumulation prior 
extracellular plaque deposition as a key contributor in AD pathology (Wirths et al., 
2004). Intraneuronal Aβ was observed already 30 years ago by Masters et al. (Masters 
et al., 1985) and has later been shown to accumulate specifically in brain regions 
vulnerable to AD (Aoki et al., 2008;Hashimoto et al., 2010). It is hypothesized that 
intracellular Aβ has two potential origins. Next to its production through intracellular 
APP cleavage, Aβ can be secreted and re-uptake might occur from the extracellular 
space. Intraneuronal Aβ, particularly Aβ42 variants, accumulate to toxic oligomers 
which ultimately cause neuronal and synaptosomal dysfunction, brain atrophy and 
dementia (Wirths et al., 2004). The hypothesis is supported by observations in Down 
syndrome patients, where intracellular Aβ was found to accumulate at young ages 
before extracellular plaque pathology is present. With age, intraneuronal Aβ decreases 
and plaques begin to deposit (Gyure et al., 2001). Furthermore, numerous mouse 
models reflect typical pathological AD hallmarks such as plaque deposition and 
inflammation, however, without showing neuron loss (Wirths et al., 2004). In contrast, 
more recently developed AD models such as APP/PS1KI (Casas et al., 2004), 5XFAD 
(Oakley et al., 2006) and Tg4-42 (Bouter et al., 2013) show an early accumulation of 
intracellular Aβ, which correlates with a neuron loss as well as behavioural deficits. All 
of these findings imply that soluble intracellular and extracellular Aβ oligomers are key 





Figure 5: The classical and modified amyloid cascade hypothesis. Adapted from (Wirths et al., 
2004).   
1.6 Aβ clearance mechanisms 
Under physiological conditions, constant levels of Aβ in the brain are maintained by a 
dynamic balance between synthesis, clearance and re-uptake of the peptide. While 
familial forms of AD are characterized by both increased Aβ synthesis rates and 
decreased Aβ clearance, sporadic AD is characterized by an impaired clearance of Aβ 
(Mawuenyega et al., 2010;Tarasoff-Conway et al., 2015). These clearance mechanisms 
implicate non-enzymatic and enzymatic pathways (Figure 6).  
1.6.1 Non-enzymatic clearance pathways 
Non-enzymatic clearance pathways of Aβ include the transport across the blood brain 
barrier (BBB) by clearance receptors. These specialized transporters are necessary as 
endothelial cells of the BBB are connected through tight junctions, which prevent Aβ 
and other proteins to freely pass into the blood (Deane and Zlokovic, 2007). The 
transporters being mainly responsible for the efflux of Aβ from the brain belong to the 
LDL receptor (LDLR) family and include LRP-1 (low-density lipoprotein receptor-
related protein-1) as well as ABC transporters (ATP-binding cassette transporters) 
(Shibata et al., 2000).  
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LRP-1 binds multiple ligands including Aβ, secreted APP, ApoE and α2-macroglobulin 
and was originally described to regulate the metabolism and transport of cholesterol 
(Harris-White and Frautschy, 2005). LRP-1 rapidly transports Aβ1-40 across the BBB 
while Aβ1-42 is removed at a much slower rate. Additionally, Aβ1-40 variants harbouring 
the Dutch mutation are cleared with less efficiency than the non-mutated version, 
delineating the role of LRP-1 function in AD pathogenesis (Monro et al., 2002).   
ABCB1 is the main ABC transporter exporting Aβ into the blood circulation. ABCB1 
does not bind Aβ directly, but transports the peptide in an ApoE-dependent manner. 
However, the precise mechanism of ABCB1-mediated Aβ clearance remains to be 
elucidated. Next to LRP1 and ABCB1, Aβ can be cleared from the brain by LRP2 and α2-
macroglobulin. The receptor being predominantly responsible for the re-entry of Aβ 
from the circulation into the brain is RAGE (receptor for advanced glycation end 
products) (Deane et al., 2003). In plasma, Aβ is bound by numerous proteins including 
albumin, α2-macroglobulin and the soluble form of LRP (sLRP) (Bates et al., 2009). 
After being transported to the liver and kidney, unbound Aβ as well as complexes of 
sLRP-Aβ become systematically cleared (Sagare et al., 2007). Next to BBB transport 
mechanisms, Aβ can be eliminated from the brain through the perivascular interstitial 
fluid (ISF) drainage pathway (Weller et al., 2000) and phagocytosis by activated 
astrocytes and microglia followed by lysosomal degradation (Rogers et al., 2002). 
1.6.2 Enzymatic clearance pathways 
Amyloid-β can be catabolized by a diversity of proteolytic enzymes which have specific 
regional and subcellular localizations, pH optima and target specificities. Hence, Aβ-
degrading enzymes (ADEs) are capable to target distinct pools of intra- and 
extracellular Aβ (Leissring, 2014;Nalivaeva et al., 2014). ADEs include, among others, 
neprilysin (NEP), endothelin-converting enzyme (ECE)-1, insulin-degrading enzyme 
(IDE), angiotensin-converting enzyme (ACE) and cathepsin D (Wang et al., 2006). In 
the following paragraph, NEP, ECE-1 and IDE will be introduced in more detail.  
The type-II metallo-endopeptidase neprilysin is ubiquitously expressed and has been 
reported to be the major ADE in the brain, where it is mainly present within neurons 
(Matsas et al., 1986;Iwata et al., 2000). NEP is also named CD10, enkephalinase or 
neutral endopeptidase and belongs to the M13 family of zinc peptidases. It is an 




active centre is facing the extracellular side of the membrane (Fukami et al., 2002). 
Besides Aβ, NEP is responsible for the degradation of diverse biologically active 
peptides such as tachykinins, enkephalins and natriuretic and chemotactic peptides 
(Turner et al., 2001). Numerous NEP cleavage sites have been identified within the Aβ 
sequence using in vitro assays (Wang et al., 2006;Miners et al., 2011), however, the 
ability of the peptidase to degrade oligomeric Aβ is still under controversial discussion 
(Kanemitsu et al., 2003;Leissring et al., 2003). Genetic depletion of NEP in AD mouse 
models results in an impaired degradation of both endogenous and exogenously 
administered Aβ (Iwata et al., 2001). In addition, inhibition of the protease by 
thiorphan results in increased accumulation of Aβ, cognitive dysfunction and a 
reduction in cholinergic activity in rats (Zou et al., 2006). On the contrary, 
overexpression of NEP ameliorates Aβ-induced spatial memory deficits in AD mouse 
models, inhibits extracellular plaque deposition and reduces Aβ accumulation (Poirier 
et al., 2006;Iijima-Ando et al., 2008;Meilandt et al., 2009). Intriguingly, it has been 
demonstrated in aged D. melanogaster, rodents and humans that NEP levels diminish 
during aging in AD vulnerable brain regions such as hippocampus, temporal gyrus and 
cortex. In contrast, brain regions rather unaffected by amyloid deposition display 
increased or unaltered steady-state levels of the protease (Yasojima et al., 
2001;Caccamo et al., 2005). Furthermore, NEP levels have been shown to be 
significantly lower in AD patients when compared to healthy controls, leading to the 
hypothesis that decreased levels of the endopeptidase and a resulting diminished Aβ 
clearance significantly contribute to the progression of the disease (Yasojima et al., 
2001).  
The endothelin-converting enzyme (ECE) induces the conversion of the inactive form 
of the potent vasoconstrictive peptide endothelin into its active version. Two different 
isoforms of ECE have been described (ECE-1 and ECE-2), however, only ECE-1 is 
supposed to act as an ADE. Like NEP, ECE-1 is a type II metallo-endopeptidase being 
predominantly localized in plasma membranes, but also in intracellular compartments. 
At the amino acid level, ECE-1 shares approximately 38% sequence homology with 
NEP (Wang et al., 2006). ECE-1 is active at a pH of 7 and has been shown to degrade Aβ 
within intracellular compartments (Eckman et al., 2001). A study in SH-SY5Y cells 
recently reported that ECE-1 degrades at least two distinct pools of Aβ, consisting of 




for secretion (Pacheco-Quinto and Eckman, 2013). In addition, mice lacking ECE-1 and 
ECE-2 display significantly higher levels of Aβ40 and Aβ42 when compared to controls, 
further emphasizing the importance of ECE in Aβ clearance (Eckman et al., 2003).    
IDE represents another zinc metallo-endopeptidase which, in addition to Aβ, has 
numerous substrates including AICD, insulin, glucagon, β-endorphin and transforming 
growth factor-α (Duckworth et al., 1998). IDE is expressed in liver, blood cells, skeletal 
muscle and brain and is active at a neutral pH. The protease is predominantly located 
in the cytosol, however, it has also been found in plasma membranes and peroxisomes 
(Wang et al., 2006). Like NEP and ECE-1, IDE has been shown to successfully degrade 
Aβ. Overexpression of IDE in mice results in a massive reduction of amyloid deposition 
and a prolonged survival rate (Hama et al., 2004). On the contrary, genetic depletion of 
IDE elevates brain Aβ levels (Farris et al., 2003). Like NEP, IDE mRNA and protein levels 
display region-dependent, reduced expression levels in aged healthy individuals as 
well as AD patients (Cook et al., 2003;Caccamo et al., 2005). Hence, IDE is another 
crucial ADE potentially playing a role in AD pathology.   
 
 
Figure 6: Aβ clearance pathways. Aβ can eliminated from the brain by enzymatic degradation, 
transport through the BBB, degradation through activated astrocytes and microglia or by the ISF 
drainage pathway. LRP2 and ABCB1 mediate the efflux of the peptide while RAGE promotes its re-entry 
into the brain. In the plasma, unbound or bound Aβ is transported to kidneys or liver and systematically 
cleared. Figure generated after (Tarasoff-Conway et al., 2015;Vandal et al., 2015).  
1.7 Mouse models of Alzheimer’s disease 
Upon the discovery of mutations in APP and PSEN genes in familial AD patients, a 

































transgenes with mutated forms of human APP and/or PSEN1/2 and mimic various 
pathological features of AD such as amyloid plaque deposition, accumulation of 
phosphorylated tau, inflammation and behavioural deficits (Elder et al., 2010). The 
first APP-based transgenic AD model was the PDAPP model harbouring the Indiana 
mutation reported by Games et al. (Games et al., 1995). Subsequently, numerous other 
mouse lines with promoters driving the expression of APP transgenes with one or more 
FAD mutations were developed (e.g. Tg2576 (Hsiao et al., 1996), APP23 (Calhoun et al., 
1999) and TgCRND8 (Chishti et al., 2001)).  
Overexpression of human mutant PSENs alone does not cause amyloid plaque 
deposition but leads to elevated levels of AβX-42. However, crossing of PSEN lines with 
APP-based transgenic mice causes early onset pathology and an extensive Aβ plaque 
load (Holcomb et al., 1998). Examples for well-characterized APP/PS1 bigenic lines are 
APP/PS1KI (Casas et al., 2004), APP/PS1ΔE9 (Borchelt et al., 1997) and 5XFAD mice 
(Oakley et al., 2006). 
As rodents do not develop Aβ plaque pathology spontaneously (Sarasa and Pesini, 
2009), the relevance of APP/PSEN mouse models is undisputed. However, due to the 
use of mutations, they only reflect the minor fraction of approximately 1% of familial 
AD cases. Thus, the generation of genetically modified mice that represent a better 
model for sporadic AD has gained particular attention in recent years. A model showing 
features of the sporadic form of AD has been developed by intracerebroventricular 
(icv) injection of streptozotozin (STZ) leading to insulin-resistance in the brain. This 
icv-STZ model is therefore based on the AD environmental risk factor diabetes mellitus 
type II and reflects important pathological characteristics of the disease such as 
memory impairment (Salkovic-Petrisic et al., 2006). Another mutation-independent 
model is the previously generated Tg4-42 model, which exclusively expresses an N-
truncated version of Aβ without APP overexpression and therefore represents the 
sporadic form of AD better than APP/PSEN-based models (Bouter et al., 2013). 
1.7.1 The Tg4-42 mouse model 
The Tg4-42 mouse model exclusively expresses the Aβ4-42 peptide, which is one of the 
most abundant Aβ species found in human AD brain (Portelius et al., 2010). The Aβ4-42 
sequence is fused to the murine thyrotropin-releasing hormone (TRH) signal peptide, 




promoter (Figure 7). Aβ accumulation correlates with the expression pattern of the 
neuron-specific promoter and occurs in a region-specific manner. Intraneuronal Aβ 
becomes apparent starting at 2 months of age in heterozygous Tg4-42 mice (Tg4-42het) 
and is predominantly present in the CA1 region of the hippocampus, but also in the 
occipital cortex, piriform cortex, striatum, superior colliculus and spinal cord. Aβ 
immunoreactivity in the CA1 layer is accompanied by an inflammatory response as 
shown by reactive micro- and astroglia. Intraneuronal CA1 Aβ immunoreactivity 
declines during aging due to a massive neuron loss, leaving mainly larger extracellular 
Aβ aggregates. The CA1 neuron loss in Tg4-42 mice happens in an age- and dose-
dependent manner. At 8 months of age, Tg4-42het animals display a 38% neuron loss 
that is even more pronounced in homozygous Tg4-42 mice (Tg4-42hom) with a 66% 
decline compared to WT controls. With 12 months of age, neurodegeneration is 
proceeded up to a loss of 50% in Tg4-42het mice. The profound neuron death in Tg4-42 
mice is accompanied by spatial reference memory deficits as assessed by the Morris 
water maze (MWM), starting with 12 months of age in heterozygous and 6 months of 
age in homozygous animals (Bouter et al., 2013). Additionally, 12-month-old Tg4-42het 
mice display an impaired contextual learning, as demonstrated in the fear conditioning 
task (Bouter et al., 2014). Despite the massive neuron loss and the subsequent memory 
decline that develops in Tg4-42 mice, this model still responds to therapeutic 
interventions. A passive immunization study using an antibody directed against Aβ4-x 
effectively decreased hippocampal neurodegeneration and rescued spatial reference 
memory deficits in Tg4-42hom mice (Antonios et al., 2015). As the Tg4-42 model neither 
expresses human APP nor possesses any mutations, it rather represents the sporadic 
form of AD and therefore demonstrates a physiologically relevant model suitable to 






Figure 7: Schematic diagram of Tg4-42 transgene. The Aβ4-42 sequence is fused to the pre-pro-TRH 
peptide. The Thy1 promoter induces the neuronal expression of the pre-pro-TRH-Aβ4-42 fusion peptide. 
The fusion peptide is directed into the ER by an N-terminal signal sequence. In the ER, signal peptidases 
liberate the pro-TRH-Aβ4-42 peptide. In the trans-Golgi network and secretory granules, prohormone 
convertases subsequently cleave off the remaining pro-TRH sequence and liberate the Aβ4-42 peptide 
(Alexandru et al., 2011). Figure generated after (Wittnam, 2012).   
1.7.2 The 5XFAD mouse model 
The conventional 5XFAD mouse model co-expresses the two human mutant transgenes 
APP and PS1 under the control of the neuron-specific Thy1 promoter (Figure 8). The 
hAPP695 transgene contains the Swedish (KM670/671NL), Florida (I716V) and 
London (V717I) mutations and PS1 harbours the mutations M146L and L286V (Oakley 
et al., 2006). These mutations are known to cause familial AD in humans and promote 
the overproduction of Aβx-42, leading to an accelerated amyloid plaque formation as 
early as 2 months of age. While the Swedish mutation promotes elevated levels of total 
Aβ, the Florida, London and PS1 mutations specifically enhance the formation of Aβ42. 
The amyloid pathology in 5XFAD mice starts with the accumulation of intraneuronal 
Aβ42 in the 5th cortical layer, rapidly followed by plaque deposition in cortex and 
subiculum. With age, Aβ plaques become detectable throughout the hippocampus and 
cortex and amyloid pathology is paralleled with massive astro- and microgliosis 
(Oakley et al., 2006;Jawhar et al., 2012). In addition to the 5th cortical layer, 5XFAD mice 
display intraneuronal Aβ accumulation in the subiculum, which correlates well with a 
significant neuron loss in these regions (Eimer and Vassar, 2013). 5XFAD mice display 
a reduced body weight compared to healthy WT animals starting with 9 months of age, 
which further aggravates over time (Jawhar et al., 2012). Concomitantly, the model 
shows a premature death phenotype, probably caused by the heavy amyloid deposition 
and subsequent cerebral vascular damage (Heraud et al., 2014). 5XFAD mice develop 














working memory deficits with 4 to 5 months of age in the Y-Maze test (Oakley et al., 
2006) and display reduced anxiety levels starting with 6 months. Furthermore, this 
strain shows an age-dependent decline in motor function starting with 9 months of age 
(Jawhar et al., 2012;Shukla et al., 2013) and significant spatial reference memory as 
well as contextual and tone memory deficits with 12 months of age (Bouter et al., 
2014). The 5XFAD model develops a rapid pathology and recapitulates the main 
features of AD. Therefore, the model is a useful tool to investigate the molecular 
mechanisms of neurodegeneration in AD (Ou-Yang and Van Nostrand, 2013;Bouter et 
al., 2014;Guzman et al., 2014;Landel et al., 2014;Anderson et al., 2015) as well as 
possible therapeutic strategies (Wirths et al., 2010;Hillmann et al., 2012;Cho et al., 
2014;Zhang et al., 2014;Devi and Ohno, 2015). 
 
 
Figure 8: Schematic diagram of 5XFAD transgenes. 5XFAD mice co-express the human APP695 and 
PS1 transgenes under the control of the neuron-specific Thy1 promoter. Mutations in Thy1-APP and 
Thy1-PS1 transgenes are indicated by arrow heads. Sw, Swedish mutation; Lon, London mutation; Fl, 
Florida mutation. Figure generated after (Oakley et al., 2006).   
1.8 Risk factors for Alzheimer’s disease 
1.8.1 Genetic risk factors 
Besides advanced age, family history is one of the major risk factors of AD (Sperling et 
al., 2011). Twin and family studies have shown that up to 80% of all AD cases involve 
the inheritance of genetic factors (Gatz et al., 2006). AD is classified into early-onset AD 
(EO-FAD) and late-onset AD (LOAD). EO-FAD develops before the age of 65 years and 
accounts for only 2-5% of all AD cases (Campion et al., 1999). This rare form of AD is 
characterized by a rapid disease progression and a Mendelian pattern of inheritance. 
So far, more than 200 different mutations in the genes encoding APP, PSEN1 and PSEN2 













inherited in a penetrant, autosomal-dominant manner and lead to elevated levels of 
Aβ42. The increase of extracellular Aβ42 promotes its aggregation and fosters cerebral 
deposition of amyloid plaques (Scheuner et al., 1996).  
Being clinically indistinguishable from EO-FAD, LOAD develops above the age of 65 and 
has no consistent mode of transmission (Bertram and Tanzi, 2005). Instead, LOAD is 
believed to be a multifactorial disease, with a combination of genetic and 
environmental factors influencing its onset. The greatest genetic risk factor linked to 
the sporadic form of AD is the ε4 allele of the lipid/cholesterol carrier apolipoprotein 
E (ApoE) on chromosome 19q3 (Strittmatter et al., 1993). In humans, three major 
polymorphisms in the ApoE gene have been described: ε2, ε3 and ε4. The ApoE ε4 allele 
is found in about 15% of the general population, while its frequency in AD patients is 
40% (Farrer et al., 1997).  The mechanism how ApoE ε4 predisposes to AD is still 
unclear, however, ApoE ε4 has been shown to codeposit and interact with Aβ (Namba 
et al., 1991). Furthermore, it has been described that ApoE ε4 modulates Aβ 
accumulation and clearance in the brain (Castellano et al., 2011). Additionally, ApoE ε4 
is supposed to impair synaptic and mitochondrial function, representing an early event 
in the onset of sporadic AD (Ji et al., 2003;Valla et al., 2010). Next to ApoE ε4, recent 
genome-wide association studies (GWAS) have found new susceptibility genes linked 
to LOAD, such as TREM2 (triggering receptor expressed on myeloid cells2) 
(Boutajangout and Wisniewski, 2013), CLU (clusterin) and PICALM 
(phosphatidylinositol-binding clathrin assembly protein) (Harold et al., 2009). 
1.8.2 Environmental risk factors 
The probability of developing LOAD is influenced by numerous environmental risk 
factors, including metabolic and cardiovascular (e.g. diabetes, midlife hypertension 
and midlife obesity) (Beydoun et al., 2008;Kennelly et al., 2009;Lu et al., 2009), 
psychological (e.g. depression) (Ownby et al., 2006) and health risk factors (e.g. 
smoking) (Cataldo et al., 2010). In addition, several studies showed that traumatic 
brain injuries in early adulthood increase the risk of developing AD in later life 
(Plassman et al., 2000). Population-based data analysis disclosed that such potentially 
modifiable risk factors cause about one third of all LOAD cases worldwide (Norton et 
al., 2014). On the other hand, several retrospective epidemiological studies suggested 




significantly reduced risk of dementia (Valenzuela, 2008;Scarmeas et al., 
2009;Scarmeas et al., 2011). For example, a study with 1449 participants showed that 
regular leisure-time physical activity at midlife lowers or delays the risk of developing 
dementia in later life (Rovio et al., 2005). In addition, a recent long-term follow-up 
study with a Finnish twin cohort revealed that vigorous physical activity protects from 
dementia and hence led to a lower mortality rate (Iso-Markku et al., 2015). Accordingly, 
a meta-analysis of 16 prospective studies led to the suggestion that 13% of all AD cases 
worldwide can be attributed to physical inactivity. A 10% reduction of physical 
inactivity could hence lead to the prevention of 380000 AD cases worldwide (Barnes 
and Yaffe, 2011). Intriguingly, beneficial effects of physical activity have also been 
proven in individuals already suffering from mild cognitive impairment and dementia 
(Heyn et al., 2004;Nagamatsu et al., 2013). There are ample mechanisms proposed how 
physical activity reduces the risk of AD and dementia (Barnes et al., 2007). First, 
physical activity lowers the risk of developing cardiovascular diseases such as diabetes 
or hypertension, which are, as previously mentioned, associated with LOAD (Profenno 
et al., 2010). Second, numerous studies in humans and animals have shown that 
physical activity has a direct beneficial effect on the structure and function of the brain 
(Cotman et al., 2007;Voss et al., 2010). As already stated, besides exercise, high 
education and cognitive stimulation throughout life are associated with a lower risk of 
AD. There is strong evidence that enhanced educational opportunities help to build up 
a cognitive reserve (CR) which enables individuals to stay asymptomatic despite 
ongoing neurodegenerative changes in the brain (Stern, 2002).  
1.9 The cognitive reserve hypothesis 
As mentioned earlier, AD is characterized by severe anatomical changes of the brain. 
Massive neuron loss leads to shrinkage of several brain areas with the hippocampus 
and cortex being primarily affected. Interestingly, a study in 1988 showed that there is 
a discrepancy between the degree of brain atrophy and the extent of clinical 
manifestation. The post mortem analysis revealed that individuals with no signs for 
cognitive decline during lifetime displayed a strong brain AD pathology (Katzman et 
al., 1988). This finding supported the idea of individual differences regarding the ability 




“cognitive reserve”. The cognitive reserve hypothesis postulates that a stimulating 
environment consisting of complex mental activities, high education, occupational 
attainment and diverse leisure activities provides a brain reserve capacity that 
tolerates brain damage to a greater extent before becoming clinically present (Stern, 
2002). Numerous following studies supported the cognitive reserve hypothesis and 
substantiated the idea that one can influence cognitive outcomes through lifestyle 
choices. For instance, individuals with high educational levels showed a 5-year delay 
in dementia onset when compared to lower educated persons (Katzman, 1993). 
Furthermore, a study with nuns revealed that a high extent of ideation and creativity 
throughout life correlates with well-preserved cognitive capacities in older age (Tyas 
et al., 2007a;Tyas et al., 2007b). In addition, a 9-year follow-up study by Paillard-Borg 
and colleagues showed that mental, social and physical activity delays the onset of 
cognitive decline. Intriguingly, a combination of all three types of activities clearly 
entailed an even stronger delay of disease onset (Paillard-Borg et al., 2012). However, 
it has to be considered that different genetically determined endowments in terms of 
brain structure and circuitry can influence the capacity to compensate certain 
disruptions as well (Stern, 2009). Therefore, it is suggestive that cognitive reserve is 
based on an interaction between genetic and environmental elements (Sale et al., 
2014). The underlying neurobiological mechanisms contributing to cognitive reserve 
might include positive effects on synaptic plasticity, synaptic connectivity, 
hippocampal neurogenesis, neuronal density, as well as cortical thickness (Stern, 
2009;Sale et al., 2014). These effects in humans have been tried to be explained by data 
obtained in animal models. Therefore, rodents are exposed to enriched environment 
(EE) paradigms, which mimic an intellectually and physically enriched lifestyle and will 
be addressed in the following paragraph. 
1.10 The environmental enrichment paradigm 
The beneficial effects of an enriched environment have first been described in 1940, 
when D.O. Hebb took a group of rats from the laboratory and let them run and play 
freely with his kids at home. When he compared these rats with the ones that remained 
under standard laboratory conditions, he observed positive effects on learning and 




later introduced the EE as a scientific paradigm (Rosenzweig et al., 1962). Ever since, 
extensive studies have revealed that rodents kept in an EE display behavioural, 
physiological and anatomical alterations. The environmental enrichment is defined as 
“a housing condition that facilitates enhanced sensory, cognitive and motor stimulation 
relative to standard housing conditions” (Nithianantharajah and Hannan, 2006) 
(Figure 9). In this experimental setting, sensory and cognitive stimulation are provided 
by numerous enrichment objects including colourful toys, climbing apparatuses, 
ladders, nesting material, houses and tunnels. The regular re-arrangement and 
exchange of EE objects (daily or weekly) provides novelty and complexity in the system 
and therefore challenges cognitive modalities such as learning and memory. In order 
to model a physically active lifestyle, EE cages can be equipped with running wheels, 
providing the continuous possibility to exercise voluntarily. In addition, the larger size 
of cages used for EE, but also the EE objects itself, encourage the animals to be more 
active and support exploration. To increase social interaction, higher numbers of 
conspecifics are maintained together in EE cages. Enriched environment protocols can 
vary substantially amongst studies, depending on the number and complexity of EE 
objects, the duration of the paradigm, the number of animals per cage and the age at 
which the protocol starts (Nithianantharajah and Hannan, 2006). However, rodents 
display highly motivated behaviours in such enriched environments. In order to handle 
these environmental demands, the brain undergoes a variety of changes (Leggio et al., 
2005;Mandolesi et al., 2008).  
 
 
Figure 9: The environmental enrichment paradigm. EE promotes physical activity, cognitive 
stimulation, somatosensory stimulation and social interaction. Figure generated after 
(Nithianantharajah and Hannan, 2006)  
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1.10.1 Benefits of environmental enrichment in rodents 
In rodents, enriched housing has been shown to have numerous positive effects on a 
cellular, molecular and behavioural level. Next to an altered cortical weight and 
thickness (Diamond et al., 1976), studies described increased branching and length of 
dendrites, increases in the number of dendritic spines and the size of synapses 
(Greenough and Volkmar, 1973;Connor et al., 1982;Turner and Greenough, 1985). 
Furthermore, EE stimulates hippocampal neurogenesis and the integration of new-
born neurons into existing neuronal circuits (Kempermann et al., 1997;1998;van Praag 
et al., 2000). It also promotes an increase in levels of neurotransmitter receptors as 
well as an elevation of neurotrophic and growth factors in the brain (Kempermann et 
al., 2010). Additionally, in brain regions that are susceptible for neurodegenerative 
changes such as hippocampus or striatum, EE has been described to induce long-term 
changes in terms of altered gene expression profiles (Li et al., 2007;Thiriet et al., 2008). 
At the behavioural level, EE has been shown to decrease anxiety and increase 
exploratory behaviour (Chapillon et al., 1999;Roy et al., 2001). Moreover, enriched 
housing diminishes memory decline in aged animals and improves cognitive function 
and sensory-motor performance (Bennett et al., 2006;Nithianantharajah and Hannan, 
2006). 
1.10.2 Benefits of environmental enrichment in AD mouse models 
As EE is thought to represent a preventative therapeutic intervention, the paradigm 
has been evaluated in numerous mouse models of AD. Regarding cognitive outcomes, 
the majority of results indicate that living in an EE has beneficial effects on AD mice. 
After long-term exposure to EE, APP23 mice displayed an improved spatial memory 
performance (Polito et al., 2014). Verret et al. found that an exposure of Tg2576 mice 
to EE prior to the onset of amyloidosis protects against cognitive impairment during 
AD pathology (Verret et al., 2013). In addition, lifelong EE counteracted age-related 
cognitive decline in both male and female PS1/PDAPP mice (Costa et al., 2007). 
However, other studies have not confirmed positive effects of EE on the cognitive 
performance of AD mouse models. For example, Cotel et al. found that after 4 months 
of continuous EE, no improvement in working memory performance was present in 




counteract memory decline in APOE ε4 mice after exposure to EE (Levi and Michaelson, 
2007). Furthermore, conflicting results regarding Aβ deposition upon EE living 
conditions have been reported. For example, some studies found a decrease in Aβ 
deposition (Yuede et al., 2009;Ke et al., 2011;Liu et al., 2013), some constant Aβ plaque 
loads (Parachikova et al., 2008;Richter et al., 2008;Cotel et al., 2012;Marlatt et al., 2013) 





1.11 Project objectives 
1.11.1 Project I: The effect of long-term environmental enrichment and physical 
activity on the pathology of Tg4-42 and 5XFAD mice  
To date, no efficacious therapeutic approach against Alzheimer’s disease has been 
developed. Hence, preventative strategies and non-pharmacological interventions to 
delay age-related cognitive changes and AD have moved into focus. Numerous 
epidemiological studies revealed that a physically and cognitively active lifestyle 
reduces the risk of developing AD (Rovio et al., 2005;Valenzuela, 2008;Scarmeas et al., 
2009). The experimental work carried out in the present doctoral thesis aims to extend 
and broaden investigations of a challenging lifestyle in combination with regular 
exercise as a potential preventative strategy for AD. To this end, the effect of long-term 
housing in an enriched environment (EE) on the newly-developed Tg4-42 as well as 
the widely-used 5XFAD mouse model will be tested. Tg4-42 mice reflect the key 
features of sporadic AD as this model overexpresses Aβ4-42 without APP mutations. 
Hence, special emphasize will lay on the effect of EE on hippocampal neuron loss and 
associated behavioural impairments. Therefore, the following questions will be 
addressed: 
- Does living in an enriched environment prevent the severe memory decline of 
Tg4-42 mice? 
- Can the CA1 neuron loss in Tg4-42 mice be delayed or rescued due to prolonged 
enriched living conditions? 
- Does mental and physical activity influence neurogenesis in aged WT and Tg4-
42 mice? 
- Are Aβ brain levels changed upon lifelong living in a physically and cognitively 
enriched environment? 
- Are gene expression profiles changed in WT and Tg4-42 mice maintained under 
enriched conditions? 






To date, the well characterized 5XFAD model has not been tested in a physically and 
mentally demanding environment. The aim of this project is to investigate, whether the 
strong behavioural and neuropathological phenotype of 5XFAD mice can be modified 
by a rather mild intervention like EE. Therefore, the aims of this part of the study can 
be summarized in main questions as follows: 
- Can the severe motor phenotype of 5XFAD mice be ameliorated due to lifelong 
EE? 
- Does cognitive and physical activity influence the behavioural changes in the 
5XFAD mouse model? 
- Are Aβ levels in 5XFAD mice modifiable through enriched living conditions? 
1.11.2 Project II: Neprilysin deficiency alters the neuropathological and 
behavioural phenotype in the 5XFAD mouse model of Alzheimer’s 
disease 
The 5XFAD mouse model represents a widely used, conventional model that develops 
major neuropathological AD hallmarks such as extracellular amyloid deposition, 
memory impairment, motor deficits and selective neuron loss (Jawhar et al., 2012). 
Neprilysin has been described to be the major Aβ-degrading enzyme in the brain and 
its role in AD pathology has been proposed in a variety of studies. The aim of this part 
of the thesis will be the analysis of the effects of neprilysin depletion in 5XFAD mice. 
Therefore, the following inquiries will be investigated: 
- Does neprilysin deficiency have an effect on the working memory performance 
of 5XFAD mice? 
- Does the lack of a neprilysin allele aggravate extracellular plaque pathology? 
- Is the inflammatory response in 5XFAD mice increased upon depletion of 
neprilysin? 




Materials and Methods 
2 MATERIALS AND METHODS  
2.1 Chemicals, Reagents and Kits  
The chemicals and reagents used in the present study are listed in Table 1, kits used 
are listed in Table 2. 




Roth, Karlsruhe, Germany 
Agarose Lonza, Basel, Switzerland  
Acetic acid Merck, Darmstadt, Germany 
Amersham Hybond-ECL Membrane GE Healthcare, Chalfont St. Gilles, GB 
Benzonase Merck, Darmstadt, Germany 
Boric acid Sigma-Aldrich, St. Louis, USA  
Bovine serum albumin (BSA) Roth, Karlsruhe, Germany 
Citric acid Roth, Karlsruhe, Germany 
Complete Mini-Protease Inhibitor Tablets Roche, Basel, Switzerland 
Complete Mini-Phosphatase Inhibitor Tablets Roche, Basel, Switzerland 
Cresyl violet Merck, Darmstadt, Germany 
Dimethyl sulfoxide Roth, Karlsruhe, Germany 
DNA ladder 100 bp Bioron, Ludwigshafen, Germany 
DNAse 10X reaction buffer with MgCl2 Thermo Fisher Scientific, Waltham, USA 
DNAse Thermo Fisher Scientific, Waltham, USA 
dNTPs  Invitrogen, Carlsbad, CA, USA 
Dulbecco’s Phosphate Buffered Salt Solution 
(DPBS) 
Pan Biotech, Aidenbach, Germany 
Ethanol, absolute Merck, Darmstadt, Germany 
Ethidium bromide Roth, Karlsruhe, Germany 
Ethylendiaminetetraacetic acid (EDTA) AppliChem, Darmstadt, Germany 
Fetal Calf Serum (FCS) Biochrom, Berlin, Germany 
Formic Acid, 98% Roth, Karlsruhe, Germany 
Hematoxylin Solution Roth, Karlsruhe, Germany 
Histofix solution containing 4% formalin Roth, Karlsruhe, Germany 
Hydrochloric acid (HCl), 37% Roth, Karlsruhe, Germany 
26 
 
Materials and Methods 
Hydrogen peroxide (H2O2) Roth, Karlsruhe, Germany 
Isopropanol Roth, Karlsruhe, Germany 
Ketamine Medistar, Ascheberg, Germany 
Methanol AppliChem, Darmstadt, Germany 
MgCl2 (25 mM) Axon, Kaiserslautern, Germany 
Molecular-grade water Braun, Melsungen, Germany 
Natrium acetate trihydrate Roth, Karlsruhe, Germany 
Non-fat Dry Milk Powder Roth, Karlsruhe, Germany 
Paraffin Roth, Karlsruhe, Germany 
Paraformaldehyde (PFA) Roth, Karlsruhe, Germany 
PCR 10X reaction buffer Axon, Kaiserslautern, Germany 
Ponceau S Roth, Karlsruhe, Germany 
Proteinase K Peqlab, Erlangen, Germany 
Roti-Histokitt Roth, Karlsruhe, Germany 
Sodium chloride (NaCl) Roth, Karlsruhe, Germany 
Sodium dodecyl sulfate (SDS) Roth, Karlsruhe, Germany 
Sodium hydroxide (NaOH) AppliChem, Darmstadt, Germany 
Sucrose Roth, Karlsruhe, Germany 
Taq polymerase Axon, Kaiserslautern, Germany 
Thioflavin S Sigma-Aldrich, St. Louis, USA  
Trifast® Peqlab, Erlangen, Germany 
Tris(hydroxymethyl)aminomethane (Tris) Roth, Karlsruhe, Germany 
Triton X-100 Roth, Karlsruhe, Germany 
Tween 20 Roth, Karlsruhe, Germany 
Xylazine (Xylariem) Ecuphar, N.V. Oostkamp, Belgium 




Table 2: Kits 
Kit Manufacturer 
Human (6E10) Abeta Peptide Ultra-Sensitive Kit Meso Scale Discovery, Rockville, USA 
RevertAid First Strand cDNA Synthesis Kit Thermo Fisher Scientific, Waltham, 
USA 
FastStart Universal SYBR Green Master (Rox) qRT-
PCR Kit 
Roche, Basel, Switzerland 
RotiQuant Universal Protein Assay Roth, Karlsruhe, Germany 
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2.2 Laboratory Animals 
2.2.1 Animal care and general conditions 
All animals used for these studies were of the species Mus musculus and were housed 
under specific-pathogen-free (SPF) conditions in the central animal facility of the 
University Medicine Göttingen (UMG). Mice were kept on a 12 hour/12 hour inverted 
dark/light cycle (light from 8.00 p.m. to 8.00 a.m.), while handling and behavioural 
testing were performed during the dark phase. Access to food and water was provided 
ad libitum. Only female mice were used in the current study. All animal experiments 
were conducted in accordance with the guidelines of the ‘Federation of European 
Laboratory Animals Science’ (GV-SOLAS) and the guidelines of the ‘Federation of 
European Laboratory Animal Science Association’ (FELASA). All animal experiments 
were approved by the ‘Lower Saxony State Office for Consumer Protection and Food 
Safety’ (LAVES). All effort was made to minimize the number and the suffering of 
animals used in the present study.  
2.2.2 Housing conditions 
2.2.2.1 Standard housing 
Mice kept under standard housing (SH) conditions were maintained in standardized 
individually ventilated cages (33 cm x 18 cm x 14 cm) in groups of 4-5 animals until the 
age of 12 months. The cages were equipped with sawdust bedding and nesting 
material. 
2.2.2.2 Environmental enrichment housing 
Mice that were assigned to environmental enrichment (EE) living conditions were 
transferred to rat cages (55 cm x 34 cm x 20 cm) after weaning until the age of 12 
months. EE cages were equipped with sawdust bedding, nesting material, tunnels, 
houses, climbing apparatuses and toys, which were cleaned, changed and re-arranged 
weekly to maintain the concept of novelty and complexity in the system 
(Nithianantharajah and Hannan, 2006). Additionally, the cages were equipped with 
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three different running wheels to promote physical activity on a voluntary basis. Mice 
were kept in groups of 4-5 animals. 
2.2.2.3 Individual cage housing 
Individual cage housing experiments were performed in collaboration with the group 
of Prof. David Liebetanz in Göttingen. For running wheel recording experiments, 2-
month-old Tg4-42hom mice were assigned to individual cages (22 cm x 16 cm x 14 cm), 
which were equipped with sawdust bedding and a running wheel (diameter of 11.3 
cm) until the age of 6 months. The running wheels of one group were freely movable 
and a rotation sensor connected to the running wheel axis transmitted the running 
activity with a resolution of 1/16 revolution and a sampling rate of 1/0.48 s to a 
customized recording device (Boenig und Kallenbach oHG). The average weekly 
running distance (km) was calculated and visualized using a custom-designed Matlab 
(The MathWorks, Inc.) program. The running wheels of the control group were blocked 
to prevent the mice from running activity while providing the same level of 
environmental enrichment.  
2.2.3 Tg4-42 transgenic mice 
The generation of Tg4-42het mice has been described previously (Bouter et al., 2013). 
In brief, Tg4-42 mice express the human Aβ4-42 sequence combined with the signal 
peptide sequence of the thyrotropin‐releasing hormone (TRH), ensuring secretion 
through the secretory pathway, under the control of the neuronal Thy1 promoter. Tg4-
42 mice were generated and maintained on a C57Bl/6J background. In addition to 
heterozygous Tg4-42 mice, a homozygous Tg4-42 line (Tg4-42hom) was generated in 
our group and used in the present study. 
2.2.4 5XFAD transgenic mice  
The generation of 5XFAD mice (Tg6799) has previously been described by Oakley and 
colleagues (Oakley et al., 2006). Briefly, 5XFAD mice overexpress the 695 amino acids 
isoform of the human amyloid precursor protein (APP695) carrying the Swedish, 
Florida and London mutations under the control of the murine Thy1 promoter. 
Additionally, human presinilin-1 (PSEN1), carrying the mutations M146L and L286V, 
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is expressed under the control of the murine Thy1 promoter. 5XFAD mice used in the 
current study were backcrossed for more than 10 generations to C57Bl/6J wild-type 
mice (WT) (Jackson Laboratories) to obtain an incipient congenic line on a C57Bl/6J 
genetic background (Jawhar et al., 2012).  
2.2.5 Neprilysin gene-disrupted mice 
The neprilysin gene-disrupted mouse model has been initially generated and described 
by Lu and colleagues (Lu et al., 1995) and was a generous gift of Dr. Takaomi Saido 
(RIKEN Brain Institute, Japan). The mice were kept as a homozygous line (NEP-/-) and 
bred with hemizygous 5XFAD mice resulting in the genotypes 5XFAD/NEP+/- and 
NEP+/-. 
2.2.6 Tissue collection and preservation 
Brain tissue was collected and preserved in different ways depending on the 
subsequent analysis: 
For RNA and protein extractions, directly frozen tissue is needed. Therefore, mice were 
sacrificed via CO2 anesthetization followed by cervical dislocation. Brains were rapidly 
dissected on ice, cerebellum and olfactory bulb were removed and hemispheres were 
separately frozen on dry ice. The tissue was kept at -80°C until further processing. 
For immunohistochemical stainings, mice were sacrificed and brains were dissected as 
described above. Hemispheres were placed into embedding cassettes (Simport) and 
stored in 4% formalin histofix solution at 4°C for at least 72 h under light protection 
until being embedded in paraffin (Section 2.6.1). 
Another way to obtain brain tissue for immunohistochemical stainings and/or 
stereological analysis is the perfusion via the vascular system through the heart. 
Therefore, mice were deeply anesthetized with a mixture of ketamine (10% stock 
solution) and xylazine (23.3 mg/ml) diluted in molecular-grade water. The anaesthetic 
was administered intraperitoneally at a dosage of 100 mg/kg ketamine and 10 mg/kg 
xylazine body weight, respectively. Once mice were no longer responsive to pain 
stimuli, they were pinned by their limbs on a perfusion board. The abdominal wall was 
opened, the diaphragm was cut and the rib cage was split to reveal the beating heart. 
The right atrium was supplied with an incision to allow blood to drain from the 
30 
 
Materials and Methods 
circulatory system. A sterile needle, which was attached to a tubing system of a 
peristaltic pump, was inserted into the left ventricle and the mouse was perfused with 
20 ml of ice-cold 0.01 M PBS to clear the circulatory system from blood. Then, the 
perfusion tubing was transferred to a cylinder containing ice-cold 4% PFA in 0.01 M 
PBS and perfusion was continued until an amount of approximately 40 ml PFA solution 
was administered. After perfusion, brain tissue was carefully collected. The right 
hemisphere was placed in 4% formalin histofix solution for post-fixation before being 
embedded in paraffin as described above. The left hemisphere was post-fixated for 
additional 24 h in 4% PFA in 0.01 M PBS before being transferred in 10 ml of 30% 
sucrose solution prepared in 0.01 M PBS. The brain tissue was incubated in sucrose 
until it sunk to the bottom of its container, subsequently frozen on dry ice and stored 
at -80°C until further use. 
2.3 Behavioural Analysis  
2.3.1 Motor phenotype assessment 
2.3.1.1 Balance Beam 
To analyse balance and fine motor coordination, the balance beam test was conducted 
(Luong et al., 2011). A 1 cm wide wooden beam was attached to two wooden support 
columns at a height of 44 cm. The surface was padded to protect against fall injuries. 
At either end of the 50 cm long beam, a 9 x 15 cm escape platform was attached. Mice 
were gently placed on the centre of the beam facing one of the platforms and released. 
The latency to fall from the beam or to reach one of the platforms was recorded. The 
test consisted of 60-seconds trials with 3 consecutive trials on a single testing day. If a 
mouse remained on the beam for the whole 60-seconds trial or escaped to one of the 
platforms, the maximum time of 60 seconds was recorded. Between each trial, the 
apparatus was cleaned with 70% ethanol to remove any olfactory cues. 
2.3.1.2 String suspension 
To test agility and grip strength, the string suspension task was performed (Arendash 
et al., 2001). The string suspension apparatus was comprised of a 50 cm long cotton 
string fixed between two wooden support beams at a height of 35 cm. The surface was 
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padded to protect against fall injuries. Mice were allowed to grasp the 3 mm thick 
cotton string only by their forepaws. During a single 60-second trial, the performance 
of each animal was assessed using a 0 to 5 rating system (Moran et al., 1995): 0 = unable 
to remain on the string; 1 = hangs only by for- or hind paws; 2 = as for 1, but with 
attempt to climb onto string; 3 = sits on string and holds balance; 4 = four paws and tail 
around string with lateral movement; 5 = escape to one of the platforms. Between each 
trial, the apparatus was cleaned with 70% ethanol to diminish odour cues. 
2.3.1.3 Rotarod 
Motor performance and motor learning were tested using the rotarod task. Testing 
consisted of four trials per day for 2 consecutive days with inter-trial intervals of 2–3 
min using a computer-controlled Rotarod system (TSE, Technical and Scientific 
Equipment). Each mouse was placed on the rod, which accelerated from 1 to 45 rpm 
over a maximum trial time of 300 seconds. Trials were terminated when animals fell 
off (or the maximum time was reached) and latency to descent (in sec) served as an 
indicator of motor coordination. Between each trial, the rotarod was cleaned with 70% 
ethanol to diminish odour cues. 
2.3.2 Y-Maze 
Working memory performance was assessed using a triangular Y-maze apparatus. The 
maze consisted of three arms (30 cm length x 8 cm width x 15 cm height), which 
extended from a triangular central region. During a 10-minute test session, each mouse 
was randomly placed at the end of one arm and was allowed to explore the Y-maze 
freely while it was tracked by the ANY-mazeTM video tracking system. Alternation was 
defined as successive arm entries into all three arms in overlapping triplet sets (e.g. 1, 
3, 2 or 3, 1, 2 but not 1, 2, 1). The percentage alternation was calculated as the ratio of 
actual alternations to possible alternations. Between each trial, the maze was cleaned 
with 70% ethanol to diminish odour cues. 
2.3.3 Cross Maze 
Spontaneous alternation rates were determined using the cross maze test (Jawhar et 
al., 2012). The cross maze apparatus was constructed of black plastic material and 
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consisted of four arms arranged in a 90° position extending from a central space of 8 x 
8 cm. Each arm was 30 cm in length, 8 cm in width and 15 cm in height. During a single 
10-minute test session, each mouse was randomly placed in 1 arm and allowed to move 
freely through the maze, while it was tracked using the ANY-mazeTM video tracking 
system. The sequence of the arm entries, the average speed as well as the total distance 
travelled was recorded. An alternation was defined as successive entries into the four 
arms in overlapping quadruple sets (e.g. 2, 3, 1, 4 or 4, 2, 1, 3 but not 2, 3, 4, 2) 
(Arendash et al., 2001). The alternation percentage was calculated as the percentage of 
actual alternations to the possible number of arm entries (n (arm entries) – 3) 
(Wietrzych et al., 2005). To standardize odours, the maze was cleaned with 70% 
ethanol after each mouse. 
2.3.4 Elevated plus maze 
The elevated plus maze tests anxiety-related behaviours in rodents (Karl et al., 2003). 
The test is based on the conflict of the animals desire to explore a novel environment 
and the avoidance of elevated open spaces due to the anxiety to fall. Therefore, the time 
spent in the open arms is an indication of the intensity of anxiety of the animal. The 75 
cm raised maze was shaped like a “+” with two open and two closed arms (15 cm length 
x 5 cm width) extending from a central platform (5 cm length x 5 cm width). Mice were 
placed individually into the centre field facing one of the closed arms and allowed to 
explore the maze freely for a single, 5 min trial. The percentage of time spent in the 
open arms as well as the ratio of open arm entries to total arm entries were measured 
using the ANY-mazeTM video tracking system. After each mouse, the maze was cleaned 
with 70% ethanol to standardize odours. 
2.3.5 Morris water maze 
Spatial reference memory abilities were evaluated using the Morris water maze 
(Morris, 1984). In this task, mice learn to locate a hidden circular platform (10 cm 
diameter) in a circular pool (110 cm diameter) filled with tap water using spatial cues. 
By adding a non-toxic white paint, the water was made opaque and maintained at 20°C 
for the whole test duration. By the use of the ANY-Maze video tracking software, the 
pool was divided into four virtual quadrants that were defined based on their spatial 
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relationship to the platform: left (L), right (R), opposite (O), and target quadrant (T), 
which contained the goal platform. Escape latency, swimming speed, swimming path 
and quadrant preference were recorded.  
Before animals were obliged to locate the submerged platform, a three-day cued 
training, in which the platform was marked with a triangular flag, was performed. Mice 
were introduced into the water at the edge of the pool facing the wall. They were given 
a maximum time of 1 min to find the platform. If mice were not able to find the platform 
in 60 sec, they were gently guided to it and allowed to sit on the platform for a few 
seconds before being removed to their cages. Between the cued training trials, both the 
location of the visible platform and the position from where mice were introduced into 
the pool, changed each time. The cued training served to evaluate the general health 
condition and intact vision of the animal. Each mouse received four cued training trials 
per day with an inter-trial interval of at least 10 minutes.  
Twenty-four hours after the last cued training trial, mice performed five days of 
acquisition training. In this part of the test, the platform was submerged and invisible 
for the animals. In addition to distal cues attached to curtains surrounding the pool, 
proximal cues were placed to the outside of the pool. Between the acquisition training 
trials, the position of the platform remained stationary while the position from where 
mice were introduced into the pool changed each time (Vorhees and Williams, 2006). 
Again, each mouse received four trials per day.  
Twenty-four hours after the last trial of the acquisition training, the probe trial was 
performed to assess spatial reference memory. The platform was removed from the 
pool and mice were placed into the water from a novel position. Mice were allowed to 
swim freely for 1 minute and the time spent in each of the virtual quadrants as well as 
the swimming speed was recorded. During the whole testing period, mice were kept in 
front of a heat lamp between the different trials to prevent hypothermia. 
2.3.6 Novel object recognition  
The novel object recognition (NOR) test was performed in an open field box made of 
grey plastic (50 cm x 50 cm). On the first day, each mouse was given 5 min to explore 
the testing environment and become habituated. 24 h later, the 5 min exploration 
phase was performed in which the arena contained two identical objects (two red 
bricks). Again 24 h later, mice were placed in the apparatus for the 5 min test trial, now 
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with a familiar and a novel object (a red brick and a glass cylinder). The time mice spent 
with each object was recorded. The objects were cleaned with 70% ethanol between 
each animal to remove any lingering scents.  
2.4 Molecular Biology 
2.4.1 Isolation of genomic DNA and genotyping of transgenic mice 
Genomic DNA was isolated from tail biopsies. 500 µl lysis buffer (100 mM Tris/HCl [pH 
8.5], 5 mM EDTA, 0.2% dodecyl sulfate [SDS] and 200 mM NaCl) supplemented with 5 
µl Proteinase K was added to the tail biopsy and incubated at 55°C for 20 h under 
shaking conditions in a Thermomixer Compact (450 rpm). Samples were then 
centrifuged at 17,000 rpm for 20 min at 4°C (Heraeus Biofuge Stratos). The 
supernatant was transferred to a fresh 1.5 ml reaction tube containing 500 µl ice-cold 
isopropanol and inverted in order to precipitate the DNA. The sample was centrifuged 
again at 13,000 rpm for 10 min at room temperature (RT). The supernatant was 
discarded and the remaining pellet was washed with 500 µl ice-cold 70% absolute 
ethanol. After another centrifugation step at 13,000 rpm for 10 min at RT, the 
supernatant was removed and the DNA pellet was dried at 37°C in a Thermomixer 
Compact for 45 min. Genomic DNA was resuspended in 30 µl molecular-grade water 
and dissolved at 55°C overnight in a Thermomixer Compact before being stored at 4°C 
until further usage. Genomic DNA samples were diluted to a concentration of 20 ng/µl 
and used for genotyping by conventional Polymerase-chain-reaction (PCR) as follows: 
Reagents for the reaction mixtures and cycling conditions are in Table 3, Table 4, Table 
5 and Table 6, respectively. Primer details are listed in Table 9. 
PCR products were analysed using agarose gel electrophoresis. Therefore, 100 ml of 
1xTBE buffer was mixed with 2.0 g agarose to prepare a 2 % agarose gel and boiled in 
a microwave at 560 W until the agarose was dissolved. 3 µl ethidiumbromide (10 
mg/ml) was added before the agarose solution was transferred into a casting tray with 
a 20-pocket sample comb. After solidification, the comb was removed and the gel was 
placed in an electrophoresis chamber (Biorad) containing 1xTBE buffer. 10 µl PCR 
product was mixed with 2 µl of 10x agarose gel sample buffer and loaded into the wells. 
The first well was filled with 5 µl of 100 bp DNA ladder for size indication of the PCR 
products. The gel was run for 30 – 60 min at 120 V and then visualized under UV light 
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using the Gel Doc 2000 (Biorad). Gels were analysed with the Quantity One software 
program (Version 4.30; Biorad). 
 
10XTBE buffer: 108 g Tris and 55 g boric acid were dissolved in 900 ml ddH20. 40 ml 
0.5 M Na2EDTA (pH 8.0) was added and the volume was adjusted to 1 l with ddH20. 
Before use, the solution was diluted 1:10 in ddH20 to obtain 1XTBE buffer.  
Table 3: Reaction mix for Tg4-42 genotyping PCR 
Reagent Volume (µl) 
DNA (20 ng/µl) 2.0 
Aβ3-42 for2 primer 1.0 
Aβ3-42 rev2 primer 1.0 
dNTPs (2 mM) 2.0 
MgCl2 (25 mM) 1.6 
10X Reaction buffer 2.0 
ddH2O 10.2 
Tag polymerase (5 U/µl) 0.2 
Total volume per sample 20 
 
 
Table 4: Reaction mixture for 5XFAD genotyping PCR 
Reagent Volume (µl) 
DNA (20 ng/µl) 2.0 
hAPP for primer 0.5 
hAPP rev primer 0.5 
dNTPs (2 mM) 2.0 
MgCl2 (25 mM) 2.0 
10X Reaction buffer 2.0 
ddH2O 10.8 
Tag polymerase (5 U/µl) 0.2 
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Table 5: Reaction mixture for NEP knockout genotyping PCR 
Reagent Volume (µl) 
DNA (20 ng/µl) 1 
5’-ex12 primer 0.4 
3’-ex13 primer 0.2 
3’-neo(3) primer 0.5 
dNTPs (2 mM) 2.5 
MgCl2 (25 mM) 2.5 
10X Reaction buffer 2.5 
ddH2O 15.2 
Tag polymerase (5 U/µl) 0.2 
Total volume per sample 24 
 
Table 6: Cycling program for genotyping PCR 
Step Temperature Duration 
1 94°C 180 sec 
2 94°C 45 sec 
3 58°C 60 sec 
4 72°C 60 sec 
5 Repetition of steps 2-4 for 35 cycles 
6 72°C 300 sec 
7 4°C ∞ 
 
2.4.2 RNA isolation from mouse brain 
Deep frozen brain hemispheres were weighed and supplied with 1 ml Trifast® reagent 
per 100 mg brain tissue. Samples were homogenized using a glass-teflon homogenizer 
(15 strokes, 800 rpm) and incubated at RT for 5 min for dissociation of nucleoprotein 
complexes. 0.2 ml chloroform per 1 ml Trifast® was added to each sample and the 
mixture was vigorously shaken for 15 sec and then incubated for 10 min at RT. To 
separate the RNA from other cellular components, samples were centrifuged at 12,000 
x g for 15 min at 4°C. The upper RNA-containing aqueous phase was carefully 
transferred to a sterile 2 ml microcentrifuge tube containing 0.5 ml isopropanol per 1 
ml Trifast®. The samples were gently mixed and incubated on ice for 20 min for RNA 
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precipitation. After centrifugation at 12,000 x g for 10 min at 4°C, the supernatant was 
discarded and RNA pellets were washed twice with a volume of 75% absolute ethanol 
equivalent to that of isopropanol and centrifuged at 7,500 x g for 10 min at 4°C. After 
the last centrifugation step, the residual ethanol was carefully removed and RNA 
pellets were air-dried at RT. The RNA was redissolved with 30 µl of molecular grade 
water and incubated on ice for 1 h. RNA was stored at -80°C until further use. 
2.4.3 Determination of nucleic acid concentration 
DNA and RNA concentrations were determined using a Biophotometer (Eppendorf). 
80 µl of molecular grade water was used as a blank for the photometry reading prior 
to sample measurements. For each sample, 2 µl DNA or RNA were diluted with 78 µl 
molecular grade water in an Uvette® 220-1600 nm cuvette (Eppendorf). For each DNA 
and RNA sample, the 260/230 and 260/280 absorbance ratios were measured, 
respectively. Concentration measurements were considered accurate if the 260/230 
and 260/280 absorbance ratios were between 1.6 and 2.0. 
2.4.4 Reverse transcription 
Before total RNA isolated from mouse brain was used as a template for reverse 
transcription, RNA was subjected to digestion by DNAse I. Therefore, 1 µg of RNA was 
mixed with 1 µl of 10x DNAse reaction buffer (+MgCl2) and 1 µl DNase I (1 u/µl). The 
reaction mixtures were brought to a total volume of 10 µl using molecular grade water 
and then incubated for 30 min at 37°C in a LabCycle (SensoQuest). 1 µl of 25 mM EDTA 
was added to each reaction mixture to inactivate the DNAse I and samples were 
incubated for further 10 min at 65°C. The entire volume (11 µl) of the DNAse digested 
RNA sample was used as a template for cDNA synthesis.    
Reverse transcription was conducted using the RevertAid First Strand cDNA Synthesis 
Kit (Thermo Fisher Scientific) according to the manufacturer’s instructions. Therefore, 
the 11 µl of DNAse digested RNA sample were mixed with 1 µl of random hexamer 
primer, 4 µl 5x reaction buffer, 1 µl RiboLock® RNAse inhibitor (20 u/µl), 2 µl of 10 mM 
dNTP mix and 2 µl M-MuLV reverse transcriptase (20 u/µl). The total reaction volume 
of 21 µl was incubated for 5 min at 25°C, 1 h at 37°C and 5 min at 70°C in a LabCycle 
(SensoQuest). The cDNA was stored at -20°C until further use. 
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2.4.5 Quantitative real-time polymerase chain reaction (qRT-PCR) 
Gene expression analysis were performed using the FastStart Universal SYBR Green 
Master qRT-PCR Kit containing SYBR green as the intercalating fluorescent dye and 
ROX as an internal reference dye. cDNA was diluted 1:10 in molecular grade water to 
serve as a sample qPCR template. The reaction mix and the cycling program are given 
in Table 7 and Table 8, respectively. Every reaction was performed in duplicates. cDNA 
dilutions were pipetted into 200 µl qRT-PCR tubes (Biozym Scientific) followed by the 
qRT-PCR reaction mix. Using a Spectrafuge Mini (Labnet Inc.), the tubes were briefly 
centrifuged before starting the qRT-PCR reactions in the Mx3000P cycler (Stratagene). 
Raw data were collected using the MxPro Mx3000P software (Stratagene). Average Ct 
values were determined from duplicates and relative quantification was performed 
using murine β-Actin as a reference gene for normalization. The transgene levels of the 
respective genes of interest (GOIs) were normalized to those of murine β-Actin and 






For an animal (q), the level of the gene of interest (GOI) gene expression normalized to 
the expression of murine β-Actin as a reference gene and calibrated to a control animal 
(cb), ΔΔCt is calculated as follows: 
 
𝛥𝐶𝑡 =  𝐶𝑡,𝐺𝑂𝐼 −  𝐶𝑡,𝛽−𝐴𝑐𝑡𝑖𝑛 
−𝛥𝛥𝐶𝑡 =  −(𝛥𝐶𝑡,𝑞 −  𝛥𝐶𝑡,𝑐𝑏) 
Table 7: qRT-PCR reaction mixture 
Reagent Volume 
(µl) 
1:10 cDNA dilution 2.0 
SYBR Green Master Mix 
(Rox) 
10 
Primer for 0.5 
Primer rev 0.5 
ddH2O 7 
Total volume per sample 20 
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Table 8: qRT-PCR cycling program 
Step Temperature Duration 
1 95°C 10 min 
2 95°C 15 sec 
3 58°C 30 sec 
4 72°C 30 sec 
5 Repetition of steps 1-4 for 39 cycles 
6 95°C 1 min 
7 55°C 30 sec 
8 95°C 30 sec 
 
2.4.6   Primers 
All primers were purchased from Eurofins (Ebersberg) and used at a final 
concentration of 10 pmol/µl (1:10 dilution of the 100 pmol/µl primer stock prepared 
in ddH2O). The primers are listed in order of the appearance in the results part. 
Table 9: List of primers used for genotyping and qRT-PCR 
Name Sequence (5’ – 3’) Usage 
Aβ3-42 for GTGACTCCTGACCTTCCAG Genotyping 
Aβ3-42 rev GTTACGCTATGACAACACCC Genotyping 
hAPP for GTAGCAGAGGAAGAAGTG Genotyping 
hAPP rev CATGACCTGGGACATTCTC Genotyping 
5’-ex12 GCCTATTCTTACCAAATATTCTCCCAG Genotyping 
3’-ex12 TTGCGGAAAGCATTTCTGGACTCCTTG Genotyping 
3’-neo CTATCGCCTTCTTGACGAGTTCTTCT Genotyping 
Actb for ATGGAGGGGAATACAGCCC qRT-PCR 
Actb rev TTCTTTGCAGCTCCTTCGTT qRT-PCR 
BDNF for GCCTTCATGCAACCGAAGTA qRT-PCR 
BDNF rev TGAGTCTCCAGGACAGCAAA qRT-PCR 
Nr4a1 for ATTGAGCTTGAATACAGGGCA qRT-PCR 
Nr4a1 rev GCTAGAAGGACTGCGGAGC qRT-PCR 
Nfil3 for CATCCATCAATGGGTCCTTC qRT-PCR 
Nfil3 rev CTTTCTTTTCCCCCTCACG qRT-PCR 
Grin2b for AGCTTGCTGTTCAATGGATG qRT-PCR 
Grin2b rev TCTGCTCAGACTCTCACCCC qRT-PCR 
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Hspa1b for ATGACCTCCTGGCACTTGTC qRT-PCR 
Hspa1b rev GCTCGAATCCTATGCCTTCA qRT-PCR 
Cyrab for GATCCGGTACTTCCTGTGGA qRT-PCR 
Cryab rev TCTCTCCGGAGGAACTCAAA qRT-PCR 
Gabra2 for CTTTCCATTTTTGCCGAAAG qRT-PCR 
Gabra2 rev TGATAATCGGCTTAGACCAGG qRT-PCR 
Gabrb2 for TCTCCAGGCTTGCTGAAAAT qRT-PCR 
Gabrb2 rev GACCAGATTTTGGAGGTCCC qRT-PCR 
Ptgds for ACTGACACGGAGTGGATGCT qRT-PCR 
Ptgds rev CGGCCTCAATCTCACCTCTA qRT-PCR 
Dnaja4 for ATTGCCTGTTCTCCACCTTG qRT-PCR 
Dnaja4 rev CAAGTACCACCCGGACAAGA qRT-PCR 
Hsp105 for GGCTTCTACAGGCAGCTCAA qRT-PCR 
Hsp105 rev CAGAAGAAAGCAAAACCCCA qRT-PCR 
Ociad2 for GATTTGGGGCAAAACAACAG qRT-PCR 
Ociad2 rev ACGGCAATAGAAGAAAACGC qRT-PCR 
Stip1 for AGCACTGTAAGGCATCATCAA qRT-PCR 
Stip1 rev GAATTCGATTCAACGGGGT qRT-PCR 
Hsp90ab1 for ACGGACCCTTCTAAGTTGGAC qRT-PCR 
Hsp90ab1 rev TCAGCCRRGGRCATGCCAATG qRT-PCR 
Bfsp2 for GCGTTTTCTAGGACAGCCTC qRT-PCR 
Bfsp2 rev GAACTGGAAACACAACTGCG qRT-PCR 
Ndn for GTGTGGAGATTGGTCAGCCT qRT-PCR 
Ndn rev AAAGAGGTCATGGGCAGCTA qRT-PCR 
Nep for CCTCAGCCGAAACTACAAGG qRT-PCR 
Nep rev TTGCTCTCTCCAGCAAAAGC qRT-PCR 
Gfap for CCTTCTGACACGGATTTGGT qRT-PCR 
Gfap rev ACATCGAGATCGCCACCTAC qRT-PCR 
Ide for CAGGCATCGTTCATCACATT qRT-PCR 
Ide rev ACAGGTTTGCGCAGTTTTTC qRT-PCR 
Bace1 for TGGTAGTAGCGATGCAGGAA qRT-PCR 
Bace1 rev ATGTGGAGATGACCGTAGGC qRT-PCR 
Ece1 for ATTTGTGTTACCCTGGTGGG qRT-PCR 
Ece1 rev ACTTGGAGCTGGAGCCTTAG qRT-PCR 
Ece2 for CCCAGCTCCACCATGTAGTC qRT-PCR 
Ece2 rev TCATCCAGGTGGACCAGTCT qRT-PCR 
Ace for CACTGCTTGATCCTGAAGTCC qRT-PCR 
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Ace rev CGATGTTAGAGAAGCCCACC qRT-PCR 
 
2.4.7 Protein isolation from mouse brain 
Frozen hemispheres were weighed and homogenized in 700 µl TBS buffer (120 mM 
NaCl, 50 mM Tris, pH 8.0 incl. complete protease inhibitor cocktail) per 100 mg tissue 
using a R50D homogenizer at 800 rpm. The resulting solution was centrifuged at 
17,000 x g for 20 min at 4°C (Heraeus Biofuge Stratos). The TBS-soluble protein 
containing supernatant was stored at -80°C. The remaining pellet was dissolved in 800 
μl of 2 % SDS with complete protease inhibitor and sonicated with a Branson Sonifier 
100 at intensity 2 (G. Heinemann Ultraschall und Labortechnik) followed by a 
centrifugation step of 17,000 x g for 20 min at 4°C. The supernatant, which contained 
SDS-soluble proteins, was transferred to a new tube containing 1 μl of Benzonase and 
was rotated at RT for 10 min followed by storage at -80°C. 
2.4.8 Protein concentration determination 
Protein concentrations were determined using the Roti®-Quant universal colorimetric 
protein concentration analysis kit according to the manufacturer’s protocol. Briefly, a 
stock solution of 2 mg/ml albumin fraction V in 0.01 M PBS was diluted (2, 1.5, 1.0, 
0.75, 0.5, 0.25, 0.125 mg/ml and ddH2O) for the generation of a standard curve. 50 µl 
of 1:10 dilutions of protein samples as well as albumin dilutions were applied in 
triplicates into a 96-well plate. Reagent 1 and Reagent 2 were mixed in a ratio of 15:1 
and added to each well in a total volume of 100 µl. The samples were gently mixed on 
a 96-well plate mixer and incubated at 37°C for 30 min in the dark. Protein 
concentrations were measured at 490 nm using a µQuant plate reader (BioTek 
Instruments, Inc.) combined with the MikroWin 2000 software (v4.04, Mikrotek).    
2.4.9 Enzyme-linked immunosorbent assay (ELISA) analysis  
ELISA measurements were performed in collaboration with the group of Sascha 
Weggen in Düsseldorf, Germany. Protein samples were isolated as described in section 
2.4.7. Monoclonal antibody IC16 (1:250 in PBS, pH 7.2), raised against amino acids 1-
15 of the Aβ sequence, served as a capture antibody. To generate standard curves, 
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synthetic Aβ40 and Aβ42 peptides (JPT Peptide Technologies) were used. These Aβ 
peptides were solubilized in DMSO at 10 μg/mL and aliquots were stored at –80°C. 96-
well high-binding microtiter plates were incubated overnight at 4°C with the capture 
antibody. After the capture antibody was removed, freshly diluted brain samples and 
freshly diluted Aβ peptide standards (125-6000 pg/ml in PBS containing 0.05 % 
Tween-20, 1 % BSA) were added. Subsequently, C-terminal detection antibodies 
specific for Aβ40 and Aβ42 labeled with horseradish peroxidase (HRP) using the Pierce 
EZ-LinkTM Plus Activated Peroxidase kit (Thermo Fisher Scientific) were diluted in 
PBS containing 0.05 % Tween-20, 1 % BSA, added to each well, and incubated 
overnight at 4°C. Plates were washed 3 times with PBS containing 0.05 % Tween-20 
and once with PBS. Then 50 μl of TMB ELISA Peroxidase Substrate (Interchim) was 
added and incubated for 1-10 min at RT in the dark. The reaction was stopped by 
adding 50 μl of 2 M H2SO4 and the absorbance was measured using a Paradigm 
microplate reader (Beckman Coulter) at 450 nm.  
2.4.10 Electrochemiluminescence Aβ assay 
For determination of Aβ levels in whole brain hemispheres, an 
electrochemiluminescence total Aβ assay obtained from Meso Scale Discovery was 
used. The Aβ assay is based on the Human (6E10) Aβ40 Ultra-Sensitive kit. Here, the 
Aβ40 detection antibody is replaced by anti-Aβ 4G8 monoclonal antibody. Therefore, 
the total Aβ assay employs monoclonal antibody 6E10 (directed against an amino 
terminal epitope of Aβ) for capture and the monoclonal antibody 4G8 (directed against 
Aβ17-26) for detection.  
The assay was performed according to the protocol of the manufacturer and readout 
on a MSD QuickPLex SQ 120. In brief, a 96-well plate pre-coated with an Aβ antibody 
(6E10) was blocked with 3% BSA under shaking conditions at room temperature for 1 
h. After 3 washing steps with 150 μl/well of 1 X Tris Wash Buffer, 25 μl of 2 mg/ml 
protein lysates or calibrator was added per well and incubated under shaking 
conditions at room temperature for 1 h. After 3 additional washing steps, 25 μl of 
detection antibody solution (4G8) was added and again incubated with shaking for 1 h 
at room temperature in the dark. Upon 3 more washing steps, 150 μl of 1X Read Buffer 
T was added to each well and plate was read on MSD instrument. 
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2.5 Deep sequencing analysis  
Deep sequencing analysis were performed in collaboration with the Microarray and 
Deep-Sequencing Core Facility of the University Medicine Göttingen (UMG). Total RNA 
was extracted from WT and Tg4-42het SH/EE mouse brain hemispheres (n = 6 per 
group) as described in section 2.4.2. 0.5 µg of total RNA was used as start material for 
the library preparation.  The libraries were generated according to the TruSeq mRNA 
Sample Preparation Kits v2 Kit from Illumina (Cat. N°RS-122-2002). For accurate 
quantitation of cDNA libraries a fluorometric based system, the QuantiFluor™ dsDNA 
System from Promega (Mannheim, Germany) was used. The size of final cDNA libraries 
was determined by using the Fragment Analyser from Advanced Bioanalytical. The 
average of libraries was 320 bp. cDNA libraries were amplified and sequenced by using 
the cBot and HiSeq2000 from Illumina (SR; 1x50 bp; ca. 30 Mio reads per sample). 
Sequence images were transformed with Illumina software BaseCaller to bcl files, 
which were demultiplexed to fastq files with CASAVA v1.8.2. Quality check was done 
via fastqc. Read alignment was performed using STAR v2.3.0 to the hg19 reference 
genome. Data were converted and sorted by samtools 0.1.19 and reads per gene were 
counted via htseq version 0.6.1. Data analysis was performed using R/Bioconductor 
(3.0.2/2.12) with DESeq2 and gplots packages. Candidate genes were filtered to a 
minimum of FDR-corrected p-value < 0.05. For functional analysis, gene ontology 
enrichment was tested via R-package goseq. Protein-protein interactions of 
differentially expressed genes were assessed using the Search Tool for the Retrieval of 
Interacting Genes/Proteins database (STRING v10).  
2.6 Immunohistochemistry 
2.6.1 Paraffin embedding of mouse brain 
Following tissue fixation (section 2.2.6), brains were transferred in the TP Automatic 
Tissue Processor (Leica) for dehydration and paraffin immersion. Table 10 displays the 
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Table 10: Brain tissue dehydration protocol 
Reagent Time 
4% histofix 5 min 
Tap water 30 min 
50%, 60%, 70%, 80%, 90% EtOH 1 h, respectively 
100% EtOH 2 x 1 h 
Xylol  1h 
Melted paraffin 2 x 1 h 
 
The tissue was embedded in paraffin blocks after processing using an EG1140 H 
Embedding Station (Leica). Embedded brains were cut in 4 µm sagittal sections using 
a HM 335E microtome (Thermo Fisher Scientific). Sections were transferred to a 
ddH2O water bath and mounted onto Superfrost® slides (Thermo Fisher Scientific). In 
a 55°C water bath (Medax), sections were defolded and fixed onto slides before a 30 
min incubation at RT followed by an overnight incubation at 37°C before being used 
for immunohistochemistry.  
2.6.2 3, 3’-Diaminobenzidine (DAB) immunohistochemistry 
For DAB staining, sections were deparaffinized in xylol (2 x 5 min) and rehydrated in a 
series of ethanol (10 min 100% EtOH; 5 min 95% EtOH; 3 min 70% EtOH) followed by 
a 1 min incubation in ddH2O. After treatment with 0.3% H2O2 in 0.01 M PBS to block 
endogenous peroxidases, antigen retrieval was achieved by boiling sections in 0.01 M 
citrate buffer pH 6.0 (2 min at 800 W, 8 min at 80 W). After a 10 min cool down, sections 
were dipped in ddH2O for 1 min and permeabilized for 15 min in 0.1% Triton X-100 in 
0.01 M PBS. A washing step in 0.01 M PBS for 1 min was followed by 3 min incubation 
in 88% formic acid to reveal intracellular Aβ. Non-specific binding sites were blocked 
for 1 h by treatment with 10% skim milk and 4% fetal calf serum (FCS) in 0.01 M PBS 
prior to the addition of the primary antibodies. The primary antibodies were diluted to 
the desired concentrations in 10% FCS in 0.01 M PBS (Table 11). After incubation 
overnight in a humid chamber at RT, sections were washed with 0.1% Triton X-100 in 
0.01 M PBS for 15 min followed by a brief rinse in 0.01 M PBS. Then, sections were 
incubated with the respective biotinylated secondary antibodies (Table 12), which 
were diluted in 0.01 M PBS containing 10% FCS, for 1 h. At least 30 min before use, the 
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Avidin-biotin complex (ABC) solution was prepared using the Vectastain Elite ABC Kit 
according to the instructions of the manufacturer and stored at 4°C. Following a 15 min 
washing step in 0.01 M PBS, sections were incubated with 100 µl of ABC solution per 
section for 1.5 h at 37°C. After removal of the ABC solution by washing in 0.01 M PBS 
for additional 15 min, the staining was visualized using DAB as a chromogen. The DAB 
developing solution was prepared by mixing 100 µl DAB stock solution (25 mg/ml DAB 
in 50 mM Tris/HCl) with 5 ml 50 mM Tris/HCl and 2.5 µl 30% H2O2. Sections were 
incubated with the DAB developing solution until the desired staining pattern was 
seen. Then, sections were washed in 0.01 M PBS for 15 min and counterstained with 
hematoxylin for 40 seconds. Sections were dipped in tap water and washed under 
running tap water for 5 min before getting dehydrated using the following incubations: 
1 min 70% EtOH; 5 min 95% EtOH, 10 min 100% EtOH, 2 x 5 min xylol. Each section 
received 3 drops of Roti®-Histokitt mounting medium and a cover slip was applied to 
the slide.       
2.6.3 Free-floating immunohistochemistry 
As DAB immunohistochemistry in paraffin sections is not applicable for the detection 
of antigens with sensitive epitopes, they can be visualized by immunostaining in free-
floating frozen sections. Therefore, one series of frozen sections was carefully 
transferred to a 12-well net system (Costar) providing constant floating of the sections. 
First, sections were hydrated for 15 min in ice-cold 0.01 M PBS before being 
transferred to 0.3% H2O2 in 0.01 M PBS for blocking endogenous peroxidase activity. 
Sections were subsequently washed 3 x 10 min in 0.01 M PBS containing 0.1% Triton 
X-100 for membrane permeabiliziation. Unspecific binding of antibodies was blocked 
by treatment with 0.01 M PBS containing 10% FCS and 4% skim milk powder for 1 h 
at RT prior to overnight incubation in primary antibody diluted in 0.01 M PBS with 
10% FCS. On the next day, sections were washed 3 x 10 min in 0.01 M PBS containing 
0.1% Triton X-100 followed by one washing step in 0.01 M PBS for 1 min. Then, 
sections were incubated with the secondary antibody in 0.01 M PBS containing 10% 
FCS for 2 h at RT followed by three additional washing steps in 0.01 M PBS for 10 min 
each. As a next step, sections were incubated in Avidin-Biotin complex (ABC) solution 
for 1.5 h at RT. After washing, staining was visualized using DAB as described in section 
2.6.2. Sections were incubated in DAB staining solution for 4 min followed by 3 x 10 
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min washing in 0.01 M PBS. After washing, sections were mounted in PBS onto 
Superfrost slides and left to dry overnight. The next day, sections were incubated in 
0.01 M PBS for hydration before being counterstained with filtered hematoxylin for 40 
sec. After shortly being dipped in ddH2O, sections were put under running water for 5 
min. Thereafter, sections were dehydrated in baths of the following EtOH 
concentrations: 1 min 70% EtOH; 5 min 95% EtOH; 10 min 100% EtOH followed by 2 
x 5 min in xylol. As a final step, sections were embedded using Roti® Histokitt mounting 
medium.   
2.6.4 Thioflavin S staining of paraffin sections 
Thioflavin S stains aggregated forms of Aβ, but no monomers or dimers. Paraffin 
embedded sections were deparaffinized and rehydrated as described in section 2.6.2. 
Then, sections were washed 2 x 1 min in distilled water and stained with 1% Thioflavin 
S solution in distilled water for 8 min. Sections were then washed 2 x 1 min in distilled 
water and again immersed for 4 min in the Thioflavin S solution. Followed by 2 x 1 min 
washes in 80% ethanol and 3 x 1 min washes in distilled water, sections were 
counterstained with DAPI and embedded in aqueous fluorescent protecting mounting 
medium. 
2.6.5 Quantification of Aβ plaque load, Thioflavin S and GFAP 
immunoreactivity 
Extracellular Aβ plaque load and Thioflavin S signal was evaluated in cortex (Ctx), 
dentate gyrus (DG), subiculum (Subic) and thalamus (Thal) using an Olympus BX-51 
microscope equipped with a Moticam Pro 282A camera (Motic) and the ImageJ 
software package. Serial images of 100x magnification were captured on three sections 
per mouse which were at least 30 μm apart from each other. Using ImageJ the pictures 
were binarized to 8-bit black and white images and a fixed intensity threshold was 
applied defining the DAB signal or Thioflavin S signal. Measurements were performed 
for a percentaged area covered by DAB or Thioflavin S staining.  
Accordingly, for GFAP staining quantification, images of 200x magnification were 
captured and the astrocyte-covered areas were analysed as described before. The 
relative Aβ plaque load or GFAP immunoreactivity is expressed with 5XFAD-SH mice 
as the reference parameter.   
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2.6.6 Primary Antibodies 
Table 11: Primary Antibodies 
Antibody Host Epitope Working 
dilution 
Manufacturer Usage 
4G8 mouse Aβ18-22 1:10000 Covance IH 
4G8-SULFO-TAG mouse Aβ18-22 1:50 Mesoscale 
Discovery 
MSD 
IC16 mouse Aβ1-15 1:250 Generous gift of 
Sascha Weggen 
ELISA 
BAP-24 mouse Aβ40 1:500 Roche ELISA 
BAP-15 mouse Aβ42 1:500 Roche ELISA 
DCX goat Doublecortin, 
expressed by 
migrating neurons 
1:500 Santa Cruz IH 





NEP mouse Neprilysin 1:250 Santa Cruz IH 
 
2.6.7 Secondary Antibodies  
Table 12: Secondary Antibodies 
Antibody Host Conjugate Working 
dilution 
Manufacturer Usage 
anti-mouse rabbit biotinylated 1:250 Dako IH 
anti-goat rabbit biotinylated 1:250 Dako IH 
 
2.7 Quantification of neuron numbers 
2.7.1 Sample preparation 
For neuronal stereology, fixed frozen left brain hemispheres were cut into 10 series of 
30 µm thick coronal sections using a CM1850 UV cryostat (Leica). Every 10th section 
was systematically sampled and stored at -80°C until further use. One brain series was 
transferred into ice-cold 0.01M PBS, carefully mounted onto Superfrost® slides and 
dried overnight at RT. Sections were stained with cresyl violet and used for 
stereological analysis.  
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2.7.2 Cresyl violet staining 
Sections were treated 2 x 10 min in work solution A followed by 20 min in work 
solution B and again 2 x 10 min in work solution A for delipidation. As a next step, 
sections were stained twice for 8 min in filtered cresyl violet staining solution. After 
washing, sections were dehydrated by incubating them 3 x 10 min in 100% EtOH, 10 
min in isopropanol and 2 x 5 min in xylol. Slides were mounted with 5 drops of Roti®-
Histokitt mounting medium and a cover slip was applied to the slide. 
  
Work solution A: 13.61 g Natrium Acetate Trihydrate was diluted in 100 ml ddH2O to 
produce a 1 M Natrium Acetate solution. 40 ml of 1 M Natrium Acetate solution was 
mixed with 9.6 ml 100% Acetic acid and the volume was adjusted to 1 l with ddH2O   
 
Work solution B: 2 ml Triton X-100 was dissolved in 10 ml ddH2O. 2.5 ml of this 
solution was mixed with 50 ml ddH2O and 150 ml 100% EtOH. 
 
Cresyl violet staining solution: 0.1 g cresyl violet was added to 1 l work solution A and 
stirred overnight under light protection.  
2.7.3 Stereological analysis 
2.7.3.1 Quantification of total neuron numbers in CA1 area and dentate gyrus 
of the hippocampus 
Design-based stereological analysis were performed on cresyl violet stained brain 
sections to quantify the neuron numbers in the CA1 pyramidal cell layer and the 
subgranular cell layer of the dentate gyrus in an unbiased manner. Therefore, a BX51 
stereology work station (Olympus) with a motorized specimen stage for automatic 
sampling and the Stereo Investigator 7 software (MBF Bioscience) were used. The 
parameters used for stereological analysis of neurons in the CA1 and dentate gyrus are 
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Table 13: Parameters for stereological analysis of CA1 and dentate gyrus neuron numbers 
Parameter CA1 Dentate 
gyrus 
Sampling Grid (x) (µm) 49 133 
Sampling Grid (y) (µm) 105 75 
Sampling Grid Area (xy) (µm2) 5145 9975 
Counting Frame Width (X) 
(µm) 
14 14 
Counting Frame Height (Y) 
(µm) 
14 14 
Counting Frame Area (XY) 
(µm2) 
196 196 
asf 26.25 50.9 
ssf 10 10 
Z (µm) 5 5 
 
The CA1 area of the hippocampus or the granular cell layer of the dentate gyrus were 
delineated at a low magnification (40x), respectively (CA1: Bregma -1.22 to -3.80 mm; 
DG: Bregma -1.34 to -3.80 mm (Franklin and Paxinos, 2012) (Figure 10). Neuronal 
nuclei were sampled randomly at a high magnification (100x) using optical dissector 
probes, and the total number of neurons was subsequently estimated by the optical 
fractionator method using a 2 µm top guard zone. On every grid site, the section 
thickness was measured with a 5 µm dissector height (Z). The number of neurons was 
estimated using the following formulas: 
 
 P = 𝑎𝑠𝑓 𝑥 𝑠𝑠𝑓 𝑥 𝑡𝑠𝑓 
 
 N = ∑ (𝑃 𝑥 𝑄)𝑖𝑛𝑖=1  
 
Where: 
asf = area sampling fraction (xy/XY) 
ssf = section sampling fraction 
tsf = thickness sampling fraction (T/Z) 
P = number of neurons 
Q = total markers counted 
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Figure 10: Schematic representation of hippocampal counting areas. (A) The CA1 region (outlined 
in red) was counted from Bregma -1.22 mm to -3.80 mm. (B) The granule cell layer of the dentate gyrus 
was counted from Bregma 1.34 mm to -3.80 mm. The pictures are modified from (Franklin and Paxinos, 
2012). 
The number of doublecortin (DCX)-positive neurons within the subgranular zone 
(SGZ) of the dentate gyrus was counted using the Meander Scan platform of the Stereo 
Investigator 7 software. Sections were obtained by systematically collecting every 10th 
30 µm thick coronal frozen section. Therefore, the adult neurogenesis rate was 
obtained by multiplying the counted number of DCX-positive neurons by a factor 10.   
2.7.3.2 Estimation of volume of CA1 area and dentate gyrus of the hippocampus 
To estimate the volume of the CA1 pyramidal cell layer and the granular cell layer of 
the dentate gyrus, the Cavalieri principle was used (Rosen and Harry, 1990). The 
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V = Cavalieri’s estimator of volume  
d = distance between analysed sections (d = 300 µm) 
yi = cross-sectional area of the i-th section  
n = total number of sections 
ymax = maximal value of y (maximum area) 
t = thickness of ymax section 
2.8 Statistical analysis 
Details of statistical analysis are given in the respective results section and in the figure 
legends. Differences between groups were tested with unpaired t-test, paired t-test, 
one-way analysis of variance (ANOVA) followed by Bonferroni multiple 
comparison/unpaired t-test or two-way ANOVA followed by Bonferroni multiple 
comparison. Survival data were analysed using the log-rank test. Significance levels 
were given as follows: ***p < 0.001; **p < 0.01; *p < 0.05. The number of animals used 
for behavioural experiments as well as sample sizes used for biochemical or 
stereological analysis are given in the figure legends (n). All data were given as means 
± standard error of the mean (SEM). All statistics were performed using GraphPad 





3.1 PROJECT I: The effect of long-term environmental enrichment 
and physical activity on the pathology of Tg4-42 and 5XFAD 
mice 
Wild-type (WT), Tg4-42het and 5XFAD mice were randomly assigned to either standard 
housing (SH) or environmental enriched (EE) housing conditions at an age of 1 month 
for a duration of 11 months. At the end of either housing paradigm, mice were 
subjected to behavioural testing and sacrificed for further biochemical and/or 
stereological analysis (Figure 11).  
 
 
Figure 11: Housing conditions and experimental design. (A) Exemplary pictures of standard housing 
(SH) and environmental enrichment (EE) cages used for the study. Mice were housed in groups of 4-5. 
EE cages were equipped with colourful toys, tunnels, climbing apparatuses and three different running 
wheels. The environment was modified and rearranged completely once a week. (B) After weaning, 
female wild-type, Tg4-42het and 5XFAD mice were randomly assigned to either SH or EE housing 
conditions for 11 months. With 12 months of age, mice were behaviourally analysed followed by sacrifice 
and tissue collection.  
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3.1.1 Part I: Enriched living conditions and physical activity delays 
hippocampal neurodegeneration and rescues memory deficits in the 
Tg4-42 mouse model of Alzheimer’s disease 
3.1.1.1 The impact of environmental enrichment and voluntary exercise on the 
sensory-motor performance of Tg4-42het mice 
In order to examine the effect of enriched housing combined with voluntary exercise 
on the sensory-motor performance of Tg4-42het mice, animals were subjected to 
different motor tasks. In the balance beam test, no significant difference was detected 
between WT SH and Tg4-42het SH mice. However, Tg4-42het EE mice performed 
significantly better than Tg4-42het SH mice (One-way ANOVA, p < 0.01). No difference 
in the proportion of mice remaining on the beam or reaching the escape platform was 
noticed between WT SH and WT EE mice (Figure 12A).  
In the string suspension task, standard housed Tg4-42het displayed significant 
impairments when compared to WT SH controls (One-way ANOVA, p < 0.05). This 
phenotype was completely rescued after 11 months of enriched housing as Tg4-42het 
EE mice showed significantly higher scores compared to sedentary controls (One-way 
ANOVA, p < 0.01). Housing conditions did not affect the performance of WT animals in 
the string suspension task (Figure 12B). 
Typical phases of motor skill learning as well as motor coordination and balance were 
assessed in the rotarod task. Over eight trials in two days, WT SH, Tg4-42het SH and EE 
mice improved their ability to stay on the rotarod over each trial. No differences in the 
rotarod performance could be determined between WT SH and Tg4-42het SH mice. 
However, enriched transgenic mice showed a significantly better performance on the 
rotarod compared to standard housed Tg4-42het mice as demonstrated by overall 
higher latencies to fall (Two-way repeated measures ANOVA, p < 0.05, Figure 12C). No 








Figure 12: Effects of EE on sensory-motor performance of WT and Tg4-42het mice. (A) Tg4-42het SH 
mice and WT SH controls displayed a comparable performance in the balance beam test. However, Tg4-
42het EE mice stayed significantly longer on the beam when compared to Tg4-42het SH mice. No such 
improvement could be detected in enriched housed WT mice compared to sedentary controls. (B) Tg4-
42het SH mice performed significantly worse than WT SH mice in the string suspension test. This 
phenotype could be completely rescued upon EE with Tg4-42het EE animals performing at WT levels. No 
differences in string suspension performance were detected between WT SH and EE mice. (C)  In the 
rotarod test, Tg4-42het EE showed significantly higher latencies to fall compared to Tg4-42het SH mice. 
No differences were seen between WT controls and Tg4-42het SH animals. (A) and (B): One-way ANOVA 
followed by Bonferroni multiple comparisons. (C): Two-way repeated measures ANOVA. **p < 0.01; *p 
< 0.05. All data were given as means ± standard error of the mean (SEM). n = 7-16 per group.   
3.1.1.2 Enriched environment and voluntary exercise prevent spatial reference 
memory deficits in Tg4-42het mice 
12-month-old Tg4-42het mice display severe spatial reference memory deficits (Bouter 
et al., 2013). To analyse whether long-term environmental enrichment in combination 
with voluntary exercise leads to an amelioration of these behavioural deficits, the 
Morris water maze (MWM) test was performed. WT SH and EE as well as Tg4-42het SH 
and EE mice showed progressively decreased escape latencies over three days of cued 
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deficits bias the interpretation of the MWM result. However, Tg4-42het SH mice 
performed significantly worse than WT SH controls during the cued training as shown 
by overall higher escape latencies (Two-way repeated measures ANOVA, p = 0.0475, 
Figure 13A). All groups showed comparable swimming speeds during the whole cued 
training phase (Figure 13C).  
In the following acquisition training phase, no difference in spatial learning could be 
detected between standard housed WT and Tg4-42het mice. However, enriched housed 
WT and Tg4-42het mice displayed significantly shorter escape latencies over the whole 
5-day training period compared to their sedentary controls, respectively. This 
indicates improved spatial learning upon prolonged enrichment and physical activity 
(Two-way repeated measures ANOVA, p < 0.0199 (WT) and p < 0.0208 (Tg4-42het), 
Figure 13B). Again, no differences in swimming speed were noted during the 
acquisition training period between all groups analysed (Figure 13D).  
During the probe trial, WT SH and EE mice showed a clear, significant preference for 
the target quadrant. Standard housed Tg4-42het mice displayed no significant 
preference for the target quadrant demonstrating severe spatial reference memory 
deficits. This phenotype could be completely rescued by long-term physical and 
cognitive stimulation as Tg4-42het mice maintained under enriched conditions showed 
a clear preservation of spatial reference memory demonstrated by their target 
quadrant preference (Figure 13E).  The swimming speed was comparable between WT 
and Tg4-42het SH/EE mice in the probe trial, indicating that altered motor abilities 
could not account for the observed results (Figure 13F). Representative occupancy 
plots of all groups revealed that WT mice and enriched housed Tg4-42het mice focused 
their search on the initial platform location during the probe trial while sedentary 





Figure 13: Impaired spatial reference memory in Tg4-42het mice is restored upon EE housing. (A) 
WT SH and EE as well as Tg4-42het SH and EE mice showed decreased escape latencies over the three 
days of cued training. However, Tg4-42het SH mice displayed a significantly poorer performance than 
WT SH mice as shown by overall higher escape latencies during the entire duration of the cued training. 
(B) Similar to A, mice of all groups showed progressively reduced escape latencies over the five days of 
acquisition training. WT EE and Tg4-42het EE mice displayed an improved spatial learning performance 
compared to their sedentary control groups, respectively, as seen by lower escape latencies over the 
whole training period. (C, D) No differences in swimming speed were observed between WT and Tg4-
42het SH/EE mice in both cued and acquisition training. (E) Tg4-42het SH mice showed no preference for 
any of the quadrants during the probe trial. WT SH and EE as well as Tg4-42het EE mice displayed an 
intact spatial reference memory as they spent significantly more time in the target quadrant (T) 
compared to all the other quadrants (L, R, O). The occupancy plots indicate exemplarily the averaged 
swimming traces of WT and Tg4-42het SH/EE mice during the probe trial. (F) During the probe trial, all 
groups analysed showed comparable swimming speeds. (A-D): Two-way repeated measures ANOVA. (E, 
F): One-way ANOVA followed by Bonferroni multiple comparisons. ***p < 0.001; **p < 0.01; *p < 0.05. 
All data were given as means ± standard error of the mean (SEM). n = 7-16 per group. L = Left, R = Right, 
O = Opposite.   


































































































































































































3.1.1.3 Enriched environment combined with physical activity restores 
recognition memory in Tg4-42het mice 
The novel object recognition (NOR) task was used to measure object recognition 
memory and preference for novelty in standard and enriched housed WT and Tg4-42het 
mice (Silvers et al., 2007). On the exploration day, WT and Tg4-42het SH/EE spent an 
equal amount of time with the two presented identical objects (Figure 14A). When 
tested for recognition memory 24 h later, standard housed WT as well as enriched 
housed WT and Tg4-42het mice spent significantly more time with the novel object (N) 
compared to the familiar one (F), indicating intact object recognition memory (t-test, p 
< 0.001, respectively). Tg4-42het SH mice did not show a preference for any of the 
objects, indicating recognition memory deficits (Figure 14B). 
 
 
Figure 14: The impact of EE and physical activity on recognition memory performance. (A) The 
novel object recognition (NOR) task was used to test recognition memory. During the exploration phase 
on day one, SH and EE WT and Tg4-42het mice spent an equal amount of time with each of the similar 
objects 1 and 2 (O1, O2). (B) During the test trial, WT SH as well as enriched housed WT and Tg4-42het 
mice spent significantly more time with the novel object (N) while sedentary controls spent an equal 
amount of time with the familiar (F) and novel object. Paired t-test. *p < 0.05; ***p < 0.001. All data were 






























































3.1.1.4 The effect of environmental enrichment and voluntary exercise on 
hippocampal neuron numbers and volume in Tg4-42het mice 
Heterozygous 12-month-old Tg4-42 mice display a massive neuron loss in the CA1 
layer of the hippocampus compared to wild-type controls (Bouter et al., 2013). In order 
to analyse whether lifelong cognitive and physical stimulation positively impacts on 
CA1 neuron numbers of Tg4-42het mice, unbiased design-based stereological analyses 
were conducted. Therefore, the hippocampal CA1 pyramidal cell layer was quantified 
from Bregma -1.22 to -3.80 mm. As previously shown, stereological analysis revealed 
a 51.1% loss in CA1 neuron numbers between WT SH controls (mean = 293319.88 ± 
34662) and Tg4-42het SH mice (mean = 146346.43 ± 4655) (One-way ANOVA, p < 
0.001). However, Tg4-42het mice maintained under enriched conditions with 
permanent access to running wheels showed a 12.8% higher number of CA1 pyramidal 
neurons (mean = 165123.88 ± 3332) compared to Tg4-42het SH mice (t-test, p < 0.01), 
indicating reduced CA1  neuronal death upon EE. Housing condition did not affect the 
number of CA1 neurons in WT animals (WT EE: mean = 291750.77 ± 21897) (Figure 
15A). 
Analysis of the CA1 volume did not show significant differences related to housing 
conditions in Tg4-42het mice (Tg4-42het SH: mean = 2.412 × 108 ± 1.239 × 107 µm3; Tg4-
42het EE: mean = 2.345 × 108  ± 1.189 × 107   µm3). In contrast, enriched housed WT 
mice (mean = 3.274 × 108 ± 3.252 × 107 µm3) showed a significantly higher CA1 volume 
compared to sedentary controls (mean = 2.541 × 108 ± 1.393 × 107 µm3) (One-way 
ANOVA, p < 0.001). Despite the massive neuron loss in Tg4-42het SH mice, no CA1 
volume difference could be detected between WT SH and Tg4-42het SH mice (Figure 
15B).   
In order to investigate whether long-term effects of an EE paradigm and voluntary 
exercise influence the total neuron number of the granular cell layer of the dentate 
gyrus (DG), stereological analysis were performed in this region from Bregma -1.34 to 
-3.88 mm. However, no changes in DG granule cells could be revealed between any of 
the analysed groups (WT SH: mean = 451001 ± 61864; WT EE: mean = 517112 ± 
30443; Tg4-42het SH: mean = 509158.86 ± 16460; Tg4-42het EE mice: mean = 
527183.84 ± 22760, Figure 15C).  
Analysis of the DG volume showed no difference between Tg4-42het SH (mean = 5.376 




However, WT mice displayed a higher dentate gyrus volume upon EE (mean = 5.434× 
108 ± 5.161 × 107 µm3) compared to standard housed controls (mean = 4.010 × 108 ± 
6.742 × 107) (One-way ANOVA, p < 0.001). No dentate gyrus volume difference was 
seen between standard housed WT and Tg4-42het mice (Figure 15D). 
 
 
Figure 15: The effect of EE on hippocampal neuron numbers and volume. (A) Design-based 
stereological analysis revealed significantly reduced CA1 neuron numbers in Tg4-42het SH mice 
compared to WT SH littermates (-51.1%). This massive neuron loss was reduced upon enriched housing 
as Tg4-42het EE mice showed significantly higher CA1 neuron numbers (+12.8%) when compared to SH 
littermates. Housing condition had no effect on CA1 neuron numbers in WT mice.  (B) No differences in 
CA1 volume could be discovered between SH and EE Tg4-42het mice. In contrast, WT EE mice displayed 
a significantly higher CA1 volume than sedentary WT animals. (C) Stereological analysis revealed no 
differences in dentate gyrus (DG) granule cells between WT and Tg4-42het SH/EE mice. (D) No 
differences in DG volume could be discovered between SH and EE Tg4-42het mice. WT EE mice showed 
a significantly higher DG volume than WT SH mice. One-way ANOVA followed by Bonferroni multiple 
comparisons. (A) Tg4-42het SH vs. Tg4-42het EE: One-way ANOVA followed by unpaired t-test. **p < 0.01; 






























































































































































































3.1.1.5 Enriched environment and physical activity do not affect subgranular 
adult neurogenesis in Tg4-42het mice 
Frozen brain sections were stained with an antibody directed against Doublecortin 
(DCX) (Figure 16A). DCX is a marker protein being expressed in new-born, immature 
neurons. The quantification of DCX+ neurons has been shown to accurately measure 
modulations in the rate of adult neurogenesis (Couillard-Despres et al., 2005). The 
number of new-born neurons in the subgranular zone (SGZ) of the DG was significantly 
reduced in 12-month-old Tg4-42het SH mice in comparison to WT SH mice (-39.09%, 
WT SH: mean = 985 ± 195.4; Tg4-42het SH: mean = 600 ± 148.4) (One-way ANOVA, p < 
0.01). Despite higher levels of physical activity and environmental diversity, enriched 
housed Tg4-42het mice still showed very low levels of adult neurogenesis, which were 
comparable to Tg4-42het SH mice. Also WT mice did not show increased DCX+ neuron 
numbers upon enriched living conditions with 12 month of age (Figure 16B). 
 
 
Figure 16: The impact of EE on adult neurogenesis in WT and Tg4-42het mice. (A, B) New-born 
doublecortin (DCX)-positive neurons were stained and quantified in the subgranular zone (SGZ) of the 
DG. 12-month-old Tg4-42het SH showed significantly reduced neurogenesis levels compared to standard 
housed WT mice. This marginal adult neurogenesis could not be restored upon enriched living 
conditions at that age in Tg4-42het mice.  Housing condition also had no effect on adult neurogenesis in 
WT animals. (B): One-way ANOVA followed by Bonferroni multiple comparisons. **p < 0.01. All data 
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3.1.1.6 The effect of long-term cognitive and physical stimulation on Aβ brain 
levels in Tg4-42het mice 
Tg4-42 mice display strong intraneuronal Aβ immunoreactivity predominantly in the 
CA1 region of the hippocampus starting with 2 months of age. Due to massive neuron 
loss, CA1 Aβ immunoreactivity is declining during aging, showing mainly larger, 
extracellular aggregates by the age of 12 months (Wittnam, 2012). In order to evaluate 
if enriched living conditions combined with voluntary exercise are accompanied by 
decreased levels of Aβ4-42 in Tg4-42het mice, immunohistochemical stainings using a 
pan-Aβ antibody (4G8) were performed in enriched and sedentary animals. 
Qualitatively, no differences in Aβ immunoreactivity could be determined between 
Tg4-42het SH and EE mice (Figure 17A).  
To further confirm this result quantitatively, brain Aβ levels of Tg4-42het SH and EE 
mice were measured using an electrochemiluminescence Aβ assay. However, no 
significant differences in Aβ levels could be detected between both groups (Tg4-42het 
SH: mean = 19.69 ± 0.69 pg/ml; Tg4-42het EE: mean = 21.74 ± 1.05 pg/ml, Figure 17B).  
 
 
Figure 17: The effect of EE and physical activity on Aβ brain levels in Tg4-42het mice. (A) 
Immunohistochemical stainings using a pan-Aβ antibody (4G8) revealed that Tg4-42het SH and EE mice 
showed a comparable Aβ staining pattern in the CA1 region of the hippocampus. (B) Using an 
electrochemiluminescence assay, Aβ levels of whole brain hemispheres were quantified. Tg4-42het SH 
and EE displayed equal amounts of the peptide. (B): Unpaired t-test. All data were given as means ± 
standard error of the mean (SEM). n = 6 per group. Scale bar: 200 µm.    
3.1.1.7 Housing under enriched conditions and physical activity changes the 
gene expression profile of WT and Tg4-42het mice 
To assess whether long-term exposure to an enriched environment and voluntary 
exercise influences the gene expression profile of WT and Tg4-42het brains, deep 


























standard and enriched housed animals. In order to demonstrate gene expression 
changes, volcano plots were created for both WT and Tg4-42het mice (Figure 18A, C). 
Each dot represents one gene that is significantly differentially regulated in WT or Tg4-
42het EE when compared to SH mice, respectively. In 12-month-old WT EE mice, 375 
genes were significantly (p < 0.05) differentially expressed when compared to SH 
controls, with 296 genes being upregulated and 79 genes being downregulated (Figure 
18A). In Tg4-42het EE mice, 155 genes were found to be significantly differentially 
expressed in comparison to their sedentary counterparts, with 80 genes being 
upregulated and 75 genes being downregulated (Figure 18C). To validate deep 
sequencing results, several differentially expressed genes (DEGs) either up- or 
downregulated were randomly selected and verified by qRT-PCR analysis. For all 
selected genes, the qRT-PCR analysis confirmed the expression levels of the deep 
sequencing results in WT and Tg4-42het mice (Figure 18B, D). A gene ontology (GO) 
analysis of the upregulated genes in WT EE mice using the String 10 software package 
revealed a significant association with several GO terms. Among those, the biological 
processes “cellular macromolecule metabolic process” (p = 1.55E-5), “gene expression” 
(p = 3.40E-4), “negative regulation of apoptotic process” (p = 5.94E-3) and “cellular 
response to stress” (p = 4.70E-2) were present. A GO analysis of the upregulated genes 
in Tg4-42het EE animals indicated an association with the biological processes “protein 
folding” (p = 7.750E-6), “response to stress” (p = 5.689E-3) and “negative regulation of 
inclusion body assembly” (p = 1.830E-2). A KEGG pathway analysis of upregulated 
genes in WT EE mice showed a significant association with several pathways like “basal 
transcription factors” (p = 9.48E-3), “glutamatergic synapse” (p = 2.04E-2) and “protein 
processing in endoplasmatic reticulum” (p = 3.49E-2). In Tg4-42het EE mice, a KEGG 
pathway analysis revealed only one significant pathway association for “protein 
processing in endoplasmatic reticulum” (p = 3.15E-9). Interestingly, 15 genes were 
identified to be upregulated upon EE in both WT and Tg4-42het mice indicating a 
common pathway associated with long-term cognitive and physical stimulation 
(Figure 18E). A GO analysis of this common subset of genes exhibited a significant 
association with the biological process “protein folding” (p = 4.73E-6) and a significant 
pathway association with “protein processing in endoplasmatic reticulum” (p = 1.55E-
5, Figure 18F). GO analysis of downregulated genes in WT EE mice showed no 




revealed a significant association with the pathway “ECM-receptor interaction” (p = 
3.11E-3). In Tg4-42het EE mice, downregulated genes showed a significant association 
with the biological process “response to stimulus” (p = 4.97E-3). However, no pathway 
was significantly associated with the downregulated genes in Tg4-42het mice upon 
enriched living conditions. 8 genes were found to be downregulated in both WT EE and 
Tg4-42het EE mice. These genes however could not be assigned to any significant 





Figure 18: Gene expression profile changes upon long-term EE in WT and Tg4-42het mice. (A, C) 
Volcano plots of significantly differentially expressed genes (DEGs) in 12-month-old WT (A) and Tg4-
42het mice (C) upon prolonged enriched living conditions. The x-axis represents the log2-fold change, the 
y-axis the p-value. White dots indicate downregulated genes, grey dots indicate upregulated genes. (B, 
D) To validate deep sequencing data, qRT-PCRs were performed in WT and Tg4-42het mice for randomly 
selected DEGs. Normalization was performed against the house-keeping gene actin. (E) Venn diagram 
analysis for genes that were significantly upregulated upon EE in both WT and Tg4-42het mice.  (F) Using 
the STRING10 software, a protein-protein interaction network of the 15 genes found to be induced upon 
EE in both WT and Tg4-42het mice was created. A significant pathway association with “protein 
processing in endoplasmatic reticulum” was found. The involved proteins are highlighted in red. (B, D): 
Unpaired t-test. ***p < 0.001;**p < 0.01; *p < 0.05. All data were given as means ± standard error of the 











































































































































































The most strongly downregulated gene upon EE in Tg4-42het mice was Necdin (NDN). 
In order to analyse whether NDN levels per se are changed under pathological 
conditions, qRT-PCR analyses were performed with WT SH/EE and Tg4-42het SH/EE 
mice. NDN expression levels were significantly increased in Tg4-42het mice when 
compared to healthy control animals (One-way ANOVA, p < 0.001). Upon enriched 
living conditions, however, NDN levels significantly decreased again in Tg4-42het mice 
(One-way ANOVA, p < 0.01). In WT animals, housing condition had no influence on 
Necdin levels (Figure 19). 
 
Figure 19: Necdin expression analysis. Tg4-42het mice display significantly increased Necdin 
expression levels when compared to healthy WT controls. However, upon enriched living conditions, 
levels drop again to baseline. In WT mice, housing condition has no effect on Necdin expression. 
Normalization was performed against the house-keeping gene actin. One-way ANOVA followed by 
Bonferroni multiple comparisons. ***p < 0.001; **p < 0.01. All data were given as means ± standard error 
of the mean (SEM). n = 6 per group.   
3.1.1.8 The effect of physical activity alone on the pathology of Tg4-42hom mice 
As the enriched environment paradigm in combination with voluntary exercise did not 
allow predictions about running wheel use of individual animals, an additional control 
experiment with homozygous Tg4-42 mice (Tg4-42hom) housed in individual cages 
equipped with either a free or blocked running wheel was performed. Tg4-42hom mice 
show a fast AD pathology progression. At 2 months of age, no difference in the number 
of neurons can be observed between Tg4-42hom mice and wild-type littermates 
(Antonios et al., 2015). However, 6-month-old Tg4-42hom mice display cognitive deficits 
and a CA1 neuronal loss comparable to 12-month-old Tg4-42het mice (Antonios et al., 


















































running wheel recordings were performed for 3.5 months. With 5.5 months of age, Tg4-
42hom mice were analysed (Figure 20A).  
Tg4-42hom mice with continuous access to running wheels showed increasing weekly 
running distances which reached a plateau from week seven on and corresponded to 
~30 km/week at the end of the trial (Figure 20B).  
In order to assess if physical activity alone is sufficient to ameliorate the neuronal cell 
death in Tg4-42 mice, stereological analysis of the CA1 pyramidal cell layer was 
performed. Single-housed Tg4-42hom mice subjected to free wheel conditions revealed 
a 16.5% increase in CA1 neuron numbers (mean = 146867.857 ± 3202) compared to 
the blocked wheel group (mean = 126120.238 ± 3422) (t-test, p < 0.001, Figure 20C). 
However, no significant differences in CA1 volume could be detected between both 
groups (Blocked wheel: mean = 1.784 × 108 ± 6.128 × 106 µm3; Free wheel: mean = 
1.945 × 108 ± 5.742 × 106 µm3) (Figure 20D). 
Due to an unexpected tail hyperflexion phenotype, which broke experimenter’s 
blindness and precluded MWM testing due to swimming incapability, the stereological 





Figure 20: The effect of physical activity on hippocampal neurodegeneration of Tg4-42hom mice. 
(A) Experimental design. 2-month-old Tg4-42hom mice were randomly assigned to single cages equipped 
with either a blocked or a free running wheel, which was connected to a rotation sensor. With 5.5 months 
of age, mice were analysed. (B) Overview of average weekly running distance (km). (C) Tg4-42hom mice 
with continuous access to a free running wheel displayed 16.5% increased CA1 pyramidal neuron 
numbers compared to mice housed in cages with a blocked wheel. (D) However, no significant CA1 
volume difference could be detected between active and inactive mice. (E) Exemplary picture of tail 
hyperflexion due to excessive running wheel usage. (C, D): Unpaired t-test. ***p < 0.001. All data were 
given as means ± standard error of the mean (SEM). n = 9 per group.  
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3.1.2 Part II: Lifelong environmental enrichment in combination with 
voluntary exercise has limited effects on the pathology of 5XFAD mice 
3.1.2.1 The effect of environmental enrichment on the physiological status and 
the sensory-motor phenotype of 5XFAD mice 
To examine if enriched housing conditions and voluntary exercise have an impact on 
the survival rate of WT and 5XFAD SH/EE mice, a survival analysis was performed.  All 
WT SH and EE mice reached the 12-month time point. 5XFAD SH mice displayed a 
premature death phenotype compared to WT SH controls as only 70% survived the 
entire paradigm (Log-rank test, p = 0.03). However, housing condition had no 
significant effect on the survival rate of 5XFAD mice (Figure 21A). 
To assess if the enriched environment has an impact on the physiological status of the 
animals, their body weight was determined at the end of each paradigm. As previously 
shown, 12-month-old 5XFAD SH mice exhibited a drastically reduced body weight 
when compared to WT SH littermates (One-way ANOVA, p < 0.001). The environmental 
enrichment in combination with long-term voluntary exercise had no influence on the 
body weight of WT or 5XFAD mice (Figure 21B).  
12-month-old 5XFAD mice show significant impairments in sensory-motor abilities 
compared to WT controls (Jawhar et al., 2012). Therefore, after 11 months spent either 
in SH or EE living conditions, the motor performance of 5XFAD mice was analysed 
using different tasks. 5XFAD SH mice performed significantly worse than age-matched 
WT SH mice in the balance beam task (One-way ANOVA, p < 0.001). This phenotype 
could not be rescued upon prolonged enriched housing. However, a significantly higher 
proportion of mice remaining on the beam or reaching the escape platform was noticed 
in WT EE mice compared to their sedentary littermates (One-way ANOVA, p < 0.01, 
Figure 21C).  
Housing conditions also had no effect on the performance of 5XFAD mice in the string 
suspension task. Both standard and enriched housed 5XFAD mice performed poorly in 
this task when compared to WT SH mice (One-way ANOVA, p < 0.001 respectively). EE 
had no effect on the string suspension performance of WT animals (Figure 21D). 
In the rotarod test, the typical phases of motor skill learning and as well as motor 
coordination and balance are assessed. With 12 months of age, 5XFAD SH mice showed 




repeated measures ANOVA, p < 0.01). This phenotype could be reversed upon enriched 
living conditions in 5XFAD EE mice as shown by overall higher latencies to fall over all 
trials (two-way ANOVA, p < 0.01, Figure 21E).  
  
Figure 21: The effect of EE and physical activity on the survival, body weight and sensory-motor 
performance of 5XFAD mice. (A) Kaplan-Meier survival curve of WT and 5XFAD mice housed under 
standard or enriched living conditions. All WT SH and EE mice survived the entire paradigm.5XFAD SH 
mice showed a premature death phenotype when compared to WT SH mice. Enriched housed 5XFAD 
displayed a tendency towards a better survival compared to 5XFAD SH mice which, however, did not 
reach statistical significance (B) Housing conditions had no effect on the significantly reduced body 
weight of 12-month-old 5XFAD mice. (C-E) The combination of EE and physical activity had limited 
effects on the sensory-motor performance of 5XFAD mice. The balance beam (C) and string suspension 
test (D) showed no improvement in enriched housed 5XFAD mice compared to sedentary controls. The 
rotarod test (E) revealed a rescue of the phenotype as 5XFAD EE mice stayed significantly longer on the 
rod when compared to 5XFAD SH mice. (A): Log-rank test. (B-D): One-way ANOVA followed by 
Bonferroni multiple comparisons. (E): Two-way repeated measures ANOVA. **p < 0.01; ***p < 0.001. All 
data were given as means ± standard error of the mean (SEM). n = 7-16 per group.           
3.1.2.2 Environmental enrichment fails to restore decreased anxiety levels and 
spatial working memory deficits in 5XFAD mice 
5XFAD mice show significantly reduced levels of anxiety in comparison to WT mice 
starting at the age of 6 months (Jawhar et al., 2012). To investigate whether this 
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was performed. 12-month-old 5XFAD SH mice displayed abnormally low levels of 
anxiety as shown by a significantly higher time spent in open arms compared to WT SH 
mice, which was not influenced by prolonged enriched living conditions (One-way 
ANOVA, p < 0.001 respectively). Housing under enriched conditions did not affect the 
anxiety phenotype of WT animals (Figure 22A). The number of arm entries did not 
differ among the groups, leading to the suggestion that reduced anxiety levels in 5XFAD 
SH and EE mice could not be explained by an overall decreased explorative behaviour 
(Figure 22B).    
To investigate whether the housing condition in combination with physical activity 
effects hippocampus-related spatial working memory, mice were tested in the cross 
maze task. As previously published, 12-month-old 5XFAD SH mice displayed a 
significantly impaired spatial working memory compared to age-matched wild-type 
controls (One-way ANOVA, p < 0.05). Enriched housed 5XFAD animals did not show an 
amelioration in spontaneous alternation behaviour when compared to sedentary 
controls as they still performed significantly worse than WT SH mice (One-way ANOVA, 
p < 0.01). Housing condition also had no effect on spatial working memory in WT 
animals (Figure 22C). Again, all analysed groups showed equal numbers of total arm 
entries indicating that the reduced alternation percentage of transgenic mice was not 





Figure 22: Anxiety-related behaviour and working memory performance in standard and 
enriched housed 5XFAD mice. (A) 5XFAD exhibited decreased levels of anxiety in the elevated plus 
maze task in both SH and EE housing conditions. Housing condition had no effect on anxiety levels of WT 
animals. (B) Decreased anxiety-related behaviour could not be explained by alterations in explorative 
behaviour, as all groups showed comparable numbers of arm entries. (C) Regarding hippocampus-
related working memory, 5XFAD mice maintained under EE conditions for 11 months showed no 
improvement in spontaneous alternation behaviour measured in the cross maze task. (D) Again, no 
differences in arm entries could be detected between all analysed groups. One-way ANOVA followed by 
Bonferroni multiple comparisons. *p < 0.05; **p < 0.01; ***p < 0.001. All data were given as means ± 
standard error of the mean (SEM). n = 7-16 per group.   
3.1.2.3 Long-term physical and cognitive stimulation does not influence 
amyloid plaque load and Aβ1-42 levels in brains of 5XFAD mice 
The 5XFAD model harbours a robust Aβ plaque pathology in various brain areas at the 
age of 12 months (Oakley et al., 2006). In order to investigate if amyloid deposition is 
affected by enriched living conditions and physical exercise, a plaque load 



















































































































































enriched and sedentary animals. Hence, immunohistochemical stainings using an anti 
Aβ antibody to quantitatively examine Aβ deposition were performed (Figure 23A). 
Brains of 5XFAD SH and EE mice showed a comparable Aβ plaque load in all areas 
analysed (Figure 23B). 
Using mass spectrometric analysis it has been shown that Aβ1-42 is the most dominant 
Aβ species in the brain of 5XFAD mice (Wittnam, 2012). To determine whether housing 
condition and voluntary exercise have an impact on Aβ1-42 levels, ELISA experiments 
were conducted to measure Aβ1-42 contents in TBS-soluble and insoluble (SDS soluble) 
brain fractions. No differences in Aβ1-42 levels could be detected in either fraction 
between sedentary 5XFAD mice and enriched housed littermates (Figure 23C, D) 
(ELISA measurements were performed by Sandra Baches, Department of 
Neuropathology, Heinrich Heine University, Düsseldorf). 
 
Figure 23: Housing condition has no effect on Aβ plaque pathology and Aβ1-42 levels of 5XFAD 
mice. (A, B) Aβ plaque load in the cortex (Ctx), dentate gyrus (DG), subiculum (Subic) and thalamus 
(Thal) was unaffected by living conditions in 12-month-old 5XFAD mice. (C, D) Using ELISA, Aβ1-42 levels 
were quantified in TBS- (C) and SDS-soluble (D) brain fractions of 5XFAD SH and EE mice. No differences 
could be detected in either fraction between the two groups. Unpaired t-test. All data were given as 



























































































3.1.2.4 Housing condition has no impact on the inflammatory phenotype of 
5XFAD mice 
5XFAD mice start to develop amyloid deposits and exhibit neuroinflammation as early 
as 2 months of age (Oakley et al., 2006). To determine whether long-term voluntary 
exercise prevents activation of inflammatory pathways, immunohistochemical 
stainings and subsequent quantifications with the reactive astrocyte marker GFAP 
were performed. No differences in GFAP signal could be detected in cortex, dentate 
gyrus and thalamus between standard and enriched housed 5XFAD mice with 12 
months of age (Figure 24A, B).  
 
Figure 24: Housing condition has no influence on the inflammatory phenotype of 5XFAD mice. (A, 
B) The presence of reactive astrocytes was revealed by immunohistochemical stainings directed against 
the astrocytic marker GFAP and a quantification was performed in the cortex (Ctx), dentate gyrus (DG) 
and thalamus (Thal) of 12-month-old 5XFAD SH and EE mice. Equal levels of astrogliosis were detected 
between the two groups in all brain areas analysed. Unpaired t-test. All data were given as means ± 








































3.1.2.5 The effect of voluntary exercise on gene expression in 5XFAD mice 
To determine the effects of housing conditions on gene expression changes in 12-
month-old 5XFAD mice, qRT-PCR analysis have been conducted (Figure 25). Numerous 
studies have shown that BDNF gene expression is upregulated upon EE, which could 
be confirmed in the present study as 5XFAD EE mice showed significantly higher levels 
of the neurotrophin when compared to sedentary controls (t-test, p < 0.05).  
Proteases known to influence A levels in the brain like neprilysin (NEP), insulin-
degrading enzyme (IDE) and BACE did not show expression level changes upon long-
term environmental enrichment. However, mRNA levels of CRYAB, STIP1, HSPA1B and 
HSP105, which are members of the heat-shock protein family, were significantly 




Figure 25: Gene expression changes in enriched housed 5XFAD mice. qRT-PCR analysis of RNA 
isolated from brain hemispheres revealed significant upregulated levels of BDNF, CRYAB, STIP1, HSPA1B 
and HSP105 in enriched housed 5XFAD mice compared to sedentary controls. Expression levels of NEP, 
IDE and BACE were not changed by housing conditions. Normalization was performed against the house-
keeping gene actin. Unpaired t-test. **p < 0.01; *p < 0.05. All data were given as means ± standard error 























































3.2 Project II: Neprilysin deficiency alters the neuropathological 
and behavioural phenotype in the 5XFAD mouse model of 
Alzheimer’s disease 
3.2.1 Characterization of 5XFAD/NEP+/- mice 
In order to evaluate the effect of a reduction of the neprilysin (NEP) gene doses, NEP 
mRNA expression levels were analysed in 2.5- and 6-month-old WT, 5XFAD, 
5XFAD/NEP+/-, NEP+/- and NEP-/- animals using qRT-PCR. Interestingly, young 5XFAD 
mice showed significantly reduced NEP levels compared to WT mice (t-test, p < 0.05), 
which were further reduced in 5XFAD/NEP+/- mice (t-test, p < 0.001 compared to WT 
and 5XFAD). NEP+/- mice displayed levels comparable to 5XFAD mice at 2.5 month of 
age (Figure 26A). Neprilysin expression in 6-month-old 5XFAD mice was reduced 
when compared to WT mice, however, without reaching statistical significance. A 
hemizygous NEP knock-out led to a further significant reduction compared to 5XFAD 
mice (t-test, p < 0.05). Compared to WT mice, 5XFAD/NEP+/- showed a drastically 
reduced NEP expression, reaching less than 10% of WT levels (t-test, p < 0.001, Figure 
26B). In 2.5- as well as 6-month-old NEP-/- animals, no neprilysin expression could be 
detected.  
The successful NEP depletion was also confirmed using immunohistochemistry with 
an antibody against NEP. Compared to WT mice, 5XFAD and 5XFAD/NEP+/- mice 
showed a strongly reduced immunoreactivity, which was most prominent in the area 





Figure 26: Neprilysin mRNA and protein levels. (A) qRT-PCR analysis revealed that 5XFAD mice 
displayed significantly reduced neprilysin (NEP) mRNA levels compared to WT mice at 2.5 months of 
age, which were even further decreased in 5XFAD/NEP+/- mice. NEP+/- mice showed comparable NEP 
levels like 5XFAD mice while in NEP-/- animals, expression of the enzyme was not detectable. (B) In 6-
month-old 5XFAD mice, NEP levels were still reduced when compared to WT mice without reaching 
statistical significance. 5XFAD/NEP+/- mice showed drastically reduced NEP levels compared to WT and 
5XFAD mice. Again, no detectable expression of NEP was seen in NEP-/- mice. (C) Immunostaining in the 
hippocampus using an antibody against NEP (56C6, Santa Cruz) showed a clear NEP signal in WT mice, 
a strongly reduced immunoreactivity in 5XFAD and 5XFAD/NEP+/- and an absent signal in NEP-/- mice. 
One-way ANOVA followed by unpaired t-test. *p < 0.05; **p < 0.01; ***p < 0.001. All data were given as 
means ± standard error of the mean (SEM). n = 3-5. Scale bar: 200 µm   
3.2.2 The effect of neprilysin deficiency on the spatial working memory 
performance of 5XFAD mice 
To assess the effect of neprilysin knock-out on spatial working memory performance, 
Y-Maze and cross maze tasks were performed. No significant differences in alternation 

























































































month-old animals in both tests (data not shown). In the Y-Maze, 6-month-old 5XFAD 
mice displayed alternation rates comparable to WT mice. However, age-matched 
5XFAD/NEP+/- mice performed significantly worse when compared to WT (t-test, p < 
0.01), 5XFAD (t-test, p < 0.001), NEP+/- (t-test, p < 0.01) and NEP-/- (t-test, p < 0.01) 
animals (Figure 27A). The reduced alternation percentage of 5XFAD/NEP+/- mice was 
not due to a decreased explorative behaviour as the number of arm entries did not 
differ among the groups (Figure 27B). 
In the cross maze task, 6-month-old 5XFAD mice showed a tendency towards a reduced 
performance when compared to WT mice (t-test, p < 0.0835). 5XFAD/NEP+/- mice 
displayed alternation rates only reaching chance level (dotted line) being significantly 
different from WT animals (t-test, p < 0.01) or NEP+/- mice (t-test, p < 0.05).  Compared 
to 5XFAD mice, 5XFAD/NEP+/- animals showed a trend towards a reduced performance 
(t-test, p < 0.082, Figure 27C).  Again, the number of total arm entries did not 






Figure 27: Spatial working memory performance of 5XFAD mice upon NEP depletion. (A) 5XFAD 
mice showed no impairment in spatial working memory performance at 6 months of age when 
compared to WT controls in the Y-Maze task. However, 5XFAD/NEP+/- mice displayed a reduced working 
memory performance compared to WT, 5XFAD, NEP+/- and NEP-/- mice. (C) In the cross maze task, 
5XFAD mice showed a tendency towards a reduced alternation rate compared to WT mice, which only 
reached significance upon hemizygous NEP depletion. (B, D) The observed impairments of 
5XFAD/NEP+/- mice in the Y- and cross maze task were not due to overall reduced exploratory behaviour 
as shown by equivalent number of arm entries in all groups in both tests. One-way ANOVA followed by 
unpaired t-test. *p < 0.05; **p < 0.01; ***p < 0.001. All data were given as means ± standard error of the 
mean (SEM). n = 3-10. 
3.2.3 Region-specific increase in extracellular Aβ plaque load in aged 
5XFAD/NEP+/- mice 
5XFAD mice display extracellular Aβ deposition in various brain areas starting with 2 
months of age. To analyse whether neprilysin deficiency aggravates Aβ plaque 
pathology, plaque load was quantified in the cortex, dentate gyrus, subiculum, 
thalamus and spinal cord of 6-month-old 5XFAD and 5XFAD/NEP+/- animals using the 






















































































































































plaque load could be detected between the two groups. In contrast, 5XFAD/NEP+/- mice 
displayed a significant increase in the overall plaque load in both dentate gyrus (+32%; 
t-test, p < 0.05) and subiculum (+40%; t-test, p < 0.01) when compared to 5XFAD mice 
(Figure 28A, B). Accordingly, plaque load quantification in the cervical spinal cord 
showed a related finding with significantly increased Aβ plaque deposition in 
5XFAD/NEP+/- compared to 5XFAD mice (+74%; t-test, p < 0.05, Figure 28D).  
A fluorescent Thioflavin S staining was performed to analyse extracellular amyloid-β 
deposits with β-sheet structures. However, no statistical differences were detected in 
any of the analysed brain regions between 5XFAD and 5XFAD/NEP+/- mice (Figure 
28C). 
Protein quantification of Aβ1-40 and Aβ1-42 levels in whole brain lysates of 6-month-old 
5XFAD and 5XFAD/NEP+/- mice revealed significantly increased Aβ1-42 levels in the 
TBS-soluble fraction of 5XFAD/NEP+/- animals (t-test, p < 0.05), while Aβ1-40 levels 
where comparable between both groups (Figure 28E). Similar Aβ1-40 and Aβ1-42 levels 
were also detected in the SDS-soluble fraction of 5XFAD and age-matched 
5XFAD/NEP+/- brain lysates (Figure 28F) (ELISA measurements were performed by 







Figure 28: Aβ plaque deposition and Aβ1-42 level in 6-month-old 5XFAD and 5XFAD/NEP+/- mice. 
(A, B) Immunohistochemical staining against Aβ (A) using a pan-Aβ antibody (4G8, detecting A17-14) 
and quantification (B). An increased amyloid plaque pathology was detected in the dentate gyrus (DG) 
and subiculum (Subic) in 5XFAD/NEP+/- mice compared to 5XFAD controls. No changes were seen in 
cortex (Ctx) and thalamus (Thal). (C) Quantification of Thioflavin-S-positive deposits showed no 
difference between the two groups in all brain areas analysed. (D) Staining with the 4G8 antibody 























































































































5XFAD/NEP+/- mice. (E) 6-month-old 5XFAD/NEP+/- mice showed significantly increased soluble A1-42 
levels while A1-40 levels were unchanged in the TBS fraction. (F) In SDS-soluble fractions, no changes in 
A1-40 or A1-42 levels were detected between 5XFAD and 5XFAD/NEP+/- mice. Unpaired t-test. *p < 0.05; 
**p < 0.01. All data were given as means ± standard error of the mean (SEM). n = 4-5 per group. Scale 
bar: 100 µm. 
3.2.4 Increased astrocytosis in 5XFAD/NEP+/- mice 
To assess if the knock-out of neprilysin aggravates the inflammatory response in 
5XFAD mice, immunohistochemical stainings and quantification of astrogliosis were 
carried out in different brain regions in 6-month-old 5XFAD and 5XFAD/NEP+/- mice 
using an antibody against GFAP. 5XFAD mice lacking one NEP allele showed more 
abundant astrogliosis in the dentate gyrus (+39%; t-test, p < 0.05), cortex (+30%; t-
test, p < 0.05) and thalamus (+23%; t-test, p < 0.01) (Figure 29A, B). 
qRT-PCR analysis revealed 6- to 7-fold increased GFAP mRNA levels in 6-month-old 
5XFAD and 5XFAD/NEP+/- mice when compared to WT and NEP-/- animals. However, 
no significant difference could be determined between 5XFAD and 5XFAD/NEP+/- mice 
(Figure 29D). At the age of 2.5 months, only 5XFAD mice displayed significantly 
increased GFAP mRNA levels compared to WT (t-test, p < 0.01), 5XFAD/NEP+/- (t-test, 




Figure 29: Inflammation status of 6-month-old 5XFAD and 5XFAD/NEP+/- mice. (A, B) Using an 
antibody against the astrocytic marker GFAP, 5XFAD/NEP+/- mice showed significantly elevated 
numbers of reactive astrocytes in the dentate gyrus (DG), cortex (Ctx) and thalamus (Th) compared to 
age-matched 5XFAD mice. (C) At 2.5 months of age, GFAP mRNA levels were significantly increased in 
5XFAD mice compared to WT, 5XFAD/NEP+/-, NEP+/- and NEP-/- mice. (D) GFAP levels strongly increased 
at 6 months of age in both 5XFAD and 5XFAD/NEP+/- animals when compared to WT and NEP-/- controls. 
(B): Unpaired t-test. (C, D): One-way ANOVA followed by unpaired t-test. *p < 0.05; **p < 0.01; ***p < 
0.001. All data were given as means ± standard error of the mean (SEM). (B): n = 5 per group. (C, D):  
n = 3 per group. Scale bar: 50 µm. 
3.2.5 Amyloid pathology in young 5XFAD/NEP+/- mice 
We were interested to assess whether an increased Aβ plaque pathology upon NEP 
depletion could be detected already at earlier time-points. Hence, young 5XFAD and 
5XFAD/NEP+/- mice at 2.5 months of age were analysed with regard to extracellular 
amyloid deposition. As expected, at an age of 2.5 months, the abundance of amyloid 
plaques was strongly decreased in both groups when compared to 6-month-old mice. 
Due to the brain-wide low abundance, plaque quantification was only possible in the 





























































































































amyloid deposition compared to age-matched 5XFAD mice (-69%; t-test, p < 0.01, 
Figure 30A-C). 
Figure 30: A plaque load quantification in 2.5-month-old 5XFAD and 5XFAD/NEP+/- mice. (A-C) 
Immunohistochemical stainings using a pan-A antibody (4G8) revealed a strongly reduced plaque load 
in young 5XFAD/NEP+/- mice (C) compared to age-matched 5XFAD mice (B). Unpaired t-test. **p < 0.01.  
All data were given as means ± standard error of the mean (SEM). n = 4 per group. Scale bar 50 µm.  
3.2.6 A-degrading enzyme expression in 5XFAD and 5XFAD/NEP+/- mice  
To explore the finding of a reduced plaque load in young 5XFAD/NEP+/- mice in more 
detail, the expression levels of additional proteases known to be capable of Aβ 
degradation were measured in young and aged mice (Figure 31A, B). Young 5XFAD 
mice displayed significantly upregulated levels of insulin-degrading-enzyme (IDE) 
compared to both WT (t-test, p < 0.05) and 5XFAD/NEP+/- mice (t-test, p < 0.01). No 
difference in IDE expression levels could be detected between 6-month-old 5XFAD and 
5XFAD/NEP+/- mice. Interestingly, the expression levels of endothelin-converting 
enzyme 1 (ECE1) were significantly increased in 5XFAD/NEP+/-, NEP+/- and NEP-/-mice 
when compared to WT and 5XFAD mice at the 2.5-month-time point. However, no 
differences could be measured between the different genotypes at 6 months of age. 
Additional members of Aβ-degrading enzymes like angiotensin-converting enzyme 
(ACE) or endothelin-converting enzyme 2 (ECE2) did not show any differences in 



































Figure 31: Expression analysis of Aβ-degrading enzymes. (A, B) IDE expression was significantly 
elevated in young 5XFAD mice, whereas 5XFAD and 5XFAD/NEP+/- mice had similar levels at 6 months 
of age. Young 5XFAD/NEP+/- mice showed significantly increased ECE1 levels compared to 5XFAD mice 
which did not differ at 6 months of age. Neither ECE2 nor ACE levels were significantly different among 
the analysed genotypes at 2.5 or 6 months of age. One-way ANOVA followed by unpaired t-test. *p < 0.05; 




























































































































































































































































































































4.1 Project I: The effect of long-term environmental enrichment 
and physical activity on the pathology of Tg4-42 and 5XFAD 
mice 
4.1.1 Part I: Enriched living conditions and physical activity delays 
hippocampal neurodegeneration and rescues memory deficits in the 
Tg4-42 mouse model of Alzheimer’s disease 
4.1.1.1 Improved sensory-motor performance in enriched housed Tg4-42het 
mice   
Next to cognitive symptoms like impaired memory or aphasia, an increasing number 
of reports have associated non-cognitive symptoms like loss of motor function with the 
progression of AD (Buchman and Bennett, 2011). Even though motor impairments are 
particularly present in late stages of AD, deficits have also been reported in early stage 
patients (Scarmeas et al., 2004). However, previous studies characterizing the novel 
Tg4-42 model have shown no alterations in measures of general motor activity when 
compared to WT mice, although Aβ pathology has been found in the spinal cord of 12-
month-old animals (Wittnam, 2012). The absence of motor impairment could be 
largely validated in the present study as sedentary Tg4-42het mice performed similar 
to WT controls in the balance beam and rotarod tests, which evaluate fine motor 
coordination and balance (Luong et al., 2011;Brooks et al., 2012) (Figure 12A, C). 
However, in the string suspension task, testing motor coordination as well as grip and 
muscle strength, Tg4-42het mice showed an impaired performance compared to WT 
animals (Figure 12B). Intriguingly, Tg4-42het mice exposed to an enriched environment 
exhibited a significant improved motor performance in all implemented tasks relative 
to standard housed controls (Hüttenrauch et al., 2016). Hence, the impaired 
performance of Tg4-42het mice in the string suspension test could be completely 
rescued (Figure 12B). These observations are in accordance with recent studies in AD 
patients indicating beneficial effects of exercise on their physical performance and 
mobility (Pitkälä et al., 2013) as well as numerous analyses in rodents showing an 




2012;Ohia-Nwoko et al., 2014). Even though the increased motor performance of WT 
EE mice in comparison to standard housed controls did not reach statistical 
significance in the present study, an enhanced motor coordination has also been 
observed in physically active, healthy WT mice compared to their sedentary 
counterparts (Marlatt et al., 2012). Therefore, it is suggestive that this effect is 
independent of the genotype but rather a general consequence of the complex 
naturalistic motor stimulation induced through an environmental enrichment 
consisting of running, balancing and climbing. This is further corroborated by studies 
showing that enriched housing induces multiple morphological changes in brain areas 
coordinating motor function, such as an increased branching of dendritic trees in 
cortical pyramidal neurons, an enhanced size and arborisation of Purkinje cells as well 
as increased number of associated synapses (Uylings et al., 1978;Black et al., 1990). In 
conclusion, long-term enriched living conditions in combination with voluntary 
exercise led to an enhanced motor coordination of Tg4-42het mice, corroborating an 
effective interaction with the environmental enrichment paradigm used in this study. 
4.1.1.2 Voluntary exercise decelerates CA1 neuron loss in Tg4-42 mice  
One of the major hallmarks of AD progression is severe hippocampal atrophy caused 
by neuron death (Carter and Lippa, 2001). To date, only a small number of AD mouse 
models display a reliable hippocampal neuron loss (Wirths and Bayer, 2010). 
Interestingly, Tg4-42 mice develop an age- and gene dose-dependent neuron loss in 
the CA1 layer of the hippocampus. The neuron loss strongly correlates with 
intraneuronal Aβ4-42 accumulation and reaches approximately 51% in hemizygous 
animals at the age of 12 months (Bouter et al., 2013). In comparison, homozygous Tg4-
42 mice display a neuron loss of approximately 50% with 6 months of age (Antonios et 
al., 2015). The precise mechanisms by which Aβ, and specifically Aβ4-42, generates its 
toxicity are currently not known in detail. Former studies have shown that Aβ 
oligomers modulate pre- and postsynaptic structures and functions, thereby blocking 
long-term potentiation (LTP) (Haass and Selkoe, 2007). It has been further proposed 
that Aβ1-42 oligomers cause dysfunction of the metabotropic glutamate receptor 5 
(mGlur5) by triggering cell surface receptor clustering near or within synapses 
(Renner et al., 2010). Glabe and Kayed have shown that Aβ oligomers lead to 




downstream pathological processes. These processes incorporate calcium 
dyshomeostasis, altered signaling pathways, production of reactive oxygen species 
(ROS) and mitochondrial dysfunction which ultimately lead to cellular dysfunction and 
neuron death (Glabe and Kayed, 2006). In the current thesis, stereological analyses 
revealed that long-term cognitive and physical stimulation significantly diminished the 
CA1 neuron loss in Tg4-42 mice (Hüttenrauch et al., 2016). Tg4-42het mice maintained 
under enriched conditions with continuous access to running wheels showed a 12.8% 
higher number of CA1 pyramidal cells when compared to sedentary controls (Figure 
15A). As one can not dissect whether the effect on neuron loss can be attributed to the 
EE paradigm, voluntary exercise or a combination of both, a control experiment using 
singly housed mice in cages equipped with blocked or free running wheels was 
performed employing homozygous Tg4-42 mice (Tg4-42hom). Like Tg4-42het mice, 
physically active Tg4-42hom mice displayed significantly increased CA1 neuron 
numbers compared to mice housed in blocked wheel cages (Figure 20C). Therefore, it 
can by hypothesized that physical activity alone is sufficient to attenuate the 
pathological events triggering neuronal cell death (Hüttenrauch et al., 2016). Several 
studies support this hypothesis (Kobilo et al., 2011), however, without providing 
quantitative evidence using unbiased, design-based stereology. Um and colleagues 
showed that treadmill exercise for 12 weeks led to a decreased number of TUNEL-
positive cells in the hippocampus of Tg-NSE/PS2m mice, concluding that neuronal cell 
death in the hippocampus could be markedly decreased due to physical activity (Um et 
al., 2011). Moreover, Tapia-Rojas and colleagues recently investigated the effect of 10 
weeks of voluntary wheel running on hippocampal neuron numbers in the 
APPswe/PS1ΔE9 mouse model. The number of neurons was assessed by Nissl staining 
and subsequent manual counting of cells present in different hippocampal zones. 
Compared to WT mice, 7-month-old APPswe/PS1ΔE9 displayed significantly less 
neurons in the CA1-CA2, CA3 and dentate gyrus. After running, cell loss could be 
partially prevented in the CA3 and dentate gyrus, but not in the CA1 region (Tapia-
Rojas et al., 2015). All of these studies indicate that physical activity can activate 
processes in the brain that lead to a better survival of neurons. The possible 
mechanistic links between exercise and its neuroprotective effect will be discussed in 




4.1.1.3 Prolonged physical activity prevents the cognitive decline in Tg4-42het 
mice  
The hippocampal expression of Aβ4-42 and the severe CA1 neuron loss correlate well 
with spatial reference memory deficits in Tg4-42 mice. Tg4-42het mice display 
significant deficits with 12 months of age (Bouter et al., 2013), while homozygous 
animals develop comparable deficiencies with 6 months of age (Antonios et al., 2015). 
As mentioned earlier, both genotypes reveal a neuron loss of approximately 50% at 
that age. Former studies have assessed the cognitive decline in Tg4-42 mice using the 
Morris water maze (MWM) paradigm, a key method in the investigation of behavioural 
alterations due to changes in hippocampal circuitry (Morris, 1984). The MWM enables 
to distinguish between spatial learning, which is assessed by repeated trials in the 
acquisition training, and long-term spatial reference memory, evaluated by the 
preference for the platform quadrant when the platform is removed during the probe 
trial (Vorhees and Williams, 2006). Confirming previous studies, spatial memory was 
not impaired in the acquisition training in 12-month-old Tg4-42het SH mice compared 
to WT controls in the present study. However, an improved spatial learning upon long-
term physical activity was detected in both WT and Tg4-42het mice when compared to 
their sedentary counterparts, respectively, indicating a general beneficial effect of the 
enriched environment independent from the genotype (Figure 13B). The lack of a 
quadrant preference in the probe trial validated the previously reported spatial 
reference memory deficits in 12-month-old Tg4-42het SH mice (Figure 13E). Even 
though the MWM performance has been shown to be specifically sensitive to 
hippocampal function, lesions in other brain regions like entorhinal and perirhinal 
cortices, prefrontal cortex, cingulate cortex and neostriatum can influence the outcome 
of the test as well (D'Hooge and De Deyn, 2001). However, as Tg4-42 mice show Aβ4-42 
immunoreactivity predominantly in the CA1 region of the hippocampus, it is suggestive 
that the toxic action of the N-truncated peptide and the accompanied neuron loss in 
this specific area mainly account for the observed memory impairment. Within the 
scope of this thesis, it could be demonstrated that in addition to a delayed CA1 neuron 
loss, spatial reference memory deficits in Tg4-42het mice can be completely prevented 
by long-term physical and cognitive stimulation (Hüttenrauch et al., 2016). 12-month-
old Tg4-42het animals maintained under enriched living conditions displayed a 




This finding is in line with recent clinical data claiming that aerobic fitness improves 
the memory performance of healthy individuals and patients with mild cognitive 
impairment (Etnier et al., 2007;Nagamatsu et al., 2013;Makizako et al., 2014). 
Moreover, beneficial effects of long-term exercise on memory task performance have 
been detected in other rodent AD models (Adlard et al., 2005;Verret et al., 2013;Rao et 
al., 2015). However, in the present study, the preserved memory capacity of active Tg4-
42het mice might be explained by the diminished hippocampal neurodegeneration and 
is in good agreement with data from Antonios and colleagues. They have shown that a 
13% increase in CA1 neuron numbers upon immunization with an antibody targeting 
N-truncated Aβ was sufficient to rescue functional spatial reference memory in Tg4-
42hom mice at 6 months of age (Antonios et al., 2015). The fact that only moderate 
increases in CA1 neuron numbers, either due to physical activity as in the current study 
or a therapeutic approach by Antonios et al., can preserve memory in this mouse 
model, supports the findings of Broadbent and colleagues, who studied the relationship 
of hippocampal lesion size and spatial memory performance in rats (Broadbent et al., 
2004). They claim that after bilateral dorsal hippocampal lesions that encompass 30-
50% of the total volume, impairments in spatial memory start to be apparent. However, 
when lesion size increased from 50-100%, memory performance worsens 
dramatically. Therefore, it can be hypothesized that a certain percentage of 
hippocampal neuron loss can be compensated, while a loss of 50% and more seems to 
be critical for learning and memory performance. This is supported by the fact that 5-
month-old homozygous Tg4-42 mice display a 43% loss of CA1 neurons and first but 
mild signs of cognitive decline. With 6 months of age, the spatial reference memory 
deficits become significant and the CA1 neuron number is reduced to 50% (Antonios 
et al., 2015).    
Due to an unexpected tail hyperflexion phenotype of singly housed Tg4-42hom mice, the 
stereological data of this group could not be backed-up with MWM data. The 
hyperflexion broke experimenter’s blindness and caused a swimming incapability. 
There is not much literature existing on this phenomenon, however, it has been 
reported that such tail transformations can occur after extensive and regular running 
wheel usage for periods of at least 8 weeks (Richter et al., 2014). Therefore, it cannot 
be ruled out that the beneficial effects on spatial reference memory performance in 




voluntary exercise and not to the physical activity per se. To address this point, future 
experiments using variations in the running wheel paradigm in order to prevent the 
formation of the tail hyperflexion phenotype are planned. 
An alternative test to examine the neural basis of memory is the novel object 
recognition task (NOR) (Winters et al., 2008). In contrast to the MWM, the NOR task 
does not evaluate spatial learning and memory, but recognition memory, which is 
based on the ability to recognize a previously encountered object as familiar (Squire et 
al., 2007). For a long time, no consensus was apparent which areas of the brain are 
important for recognition memory performance. Many studies supported the 
assumption that recognition memory depends on the integrity of the medial temporal 
lobe (MTL) system, a brain structure including the hippocampus, entorhinal, perirhinal 
and parahippocampal cortices (Squire and Zola-Morgan, 1991). However, latest 
studies involving rodents, non-human primates and memory-impaired patients 
provided strong evidence that damage limited to the hippocampus is sufficient to cause 
recognition memory impairments (Squire et al., 2007;Broadbent et al., 2010). 
Consistent with these findings, an impaired recognition memory performance could be 
detected in 12-month-old Tg4-42het mice. This phenotype was completely reversed by 
housing under enriched conditions (Figure 14) (Hüttenrauch et al., 2016). O´Callaghan 
and colleagues already reported an exercise-related improvement of recognition 
memory in rats after only 7 days of forced running (O'Callaghan et al., 2007). Moreover, 
it has been shown that 4 months of voluntary wheel running led to an improved 
memory in the object recognition test in 9-month-old Tg2576 mice (Yuede et al., 2009).   
In summary, the findings of an amelioration of spatial reference and recognition 
memory deficits in enriched housed Tg4-42het mice indicate that enhanced physical 
and cognitive activity has an overall positive effect on hippocampus-dependent 
memory performances, which is not task-specific.  
4.1.1.4 Adult hippocampal neurogenesis is unaffected in enriched housed WT 
and Tg4-42het mice 
Adult hippocampal neurogenesis drastically decreases in rodents in an age-dependent 
manner (Kuhn et al., 1996). Accordingly, 12-month-old WT mice displayed only 
marginal levels of new-born neurons in the present study. However, Tg4-42het animals 




which is consistent with numerous AD mouse models displaying abnormal low, or even 
absent neurogenesis levels (Feng et al., 2001;Donovan et al., 2006). It is currently not 
known which mechanisms lead to the diminished production of neurons in AD models, 
however, one hypothesis is the inflammatory environment in diseased brains. In vivo 
data have demonstrated that new-born neurons are highly vulnerable to inflammation 
insults, shown by a negative correlation between their survival rate and the number of 
activated microglia cells (Ekdahl et al., 2003). Hence, the low neurogenesis levels in 12-
month-old Tg4-42het mice might be explained by the strong gliosis present in the 
hippocampal area due to intraneuronal Aβ accumulation (Bouter et al., 2013).   
There is vast literature reporting that environmental enriched living conditions, and 
specifically physical activity, increase hippocampal neurogenesis in rodent brains 
(Kempermann et al., 1997;van Praag et al., 1999). Surprisingly, no difference in the 
number of new-born cells could be detected between sedentary and enriched housed 
mice in both WT and Tg4-42het animals in the current work (Figure 16). This 
observation is contradictory to numerous studies that have linked the cognitive 
protection provided by EE with increased levels of subgranular neurogenesis 
(Kempermann et al., 1998;van Praag et al., 2000;van Praag et al., 2005). Even under 
deleterious conditions like chronic stress or in advanced aged animals, hippocampal 
neurogenesis has been shown to be restored through exposure to enriched 
environment (Kempermann, 2002;Veena et al., 2009). On the contrary, a study 
employing healthy WT mice by Meshi and colleagues strongly supports the finding of 
the present study. They demonstrated that a blockade of neurogenesis by exposure to 
focal X-ray irradiation did not prevent the beneficial effects of EE on their cognitive 
performance (Meshi et al., 2006). Furthermore, another report from Catlow et al. could 
not find a difference in the number of new-born neurons between standard and 
enriched housed PS1/APP mice, despite overall cognitive-enhancing effects of the 
enriched environment (Catlow et al., 2009). Therefore, it is suggestive that 
neurogenesis does not necessarily contribute to the beneficial effects induced by a 
stimulating environment. Consequently, the cognitive protection seen in enriched 




4.1.1.5 Tg4-42het SH and EE mice display unaltered brain A levels 
N-truncated Aβ4-42 is one of the major species in the cortex and hippocampus of AD 
patients and its impact on AD pathology has long been neglected (Portelius et al., 2010). 
The Tg4-42 model exclusively expresses N-truncated Aβ4-42 fused to the TRH signal 
peptide under the control of the Thy1 promoter. The accumulation of Aβ4-42 therefore 
correlates with the expression pattern of the neuron-specific promoter and occurs in a 
region-specific manner (Caroni, 1997). Intraneuronal Aβ is detectable starting from 2 
months of age and is predominantly present in the CA1 region of the hippocampus. 
However, due to the massive neuron loss, intracellular Aβ4-42 reactivity declines with 
age, leaving mainly larger extracellular Aβ aggregates as remnants of disintegrated 
neurons by the age of 12 months (Figure 17A). This phenomenon has also been 
observed in human AD patients. Brain regions with an excessive intracellular Aβ42 
accumulation showed evidence of neuronal death, resulting in the release and 
dispersion of the peptides to the extracellular space where they contributed to the 
formation of plaques (D'Andrea et al., 2001).  
Improved memory performance and a reduced neuron loss in Tg4-42het mice upon 
enriched environment was not accompanied by decreased levels of Aβ4-42 in the 
present study (Figure 17B) (Hüttenrauch et al., 2016). Therefore, it can be speculated 
that the cognitive improvement and the neuroprotective effect induced by long-term 
environmental and physical stimulation is not dependent on a simple reduction in Aβ 
levels. This is in contrast to many other studies on enriched environment in AD mouse 
models showing reduced Aβ levels upon continuous exercise. Rao and colleagues 
recently reported that environmental enrichment lowered total, soluble and insoluble 
Aβ levels in both cortex and hippocampus of active APP/PSEN1 mice while they 
concurrently showed an improved cognition (Rao et al., 2015). In addition, Lazarov et 
al. reported decreased levels of Aβ upon enrichment in another AD model which they 
explained by enhanced levels of the Aβ-degrading enzyme neprilysin (NEP) through 
long-term exercise (Lazarov et al., 2005). However, it is worth noting that a study by 
Costa and colleagues revealed decreased levels of Aβ deposition upon enrichment in 
double transgenic PS1/PDAPP mice without being able to correlate their cognitive 
performance with the Aβ pathology (Costa et al., 2007). This supports the finding of the 




irrespective of brain Aβ levels. However, it cannot be ruled out that despite unchanged 
total Aβ levels, long-term exercise has an impact on conformational changes of the 
peptide resulting in reduced neurotoxicity. This hypothesis will be further discussed in 
the next section.  
4.1.1.6 Gene expression changes underlying the beneficial effects of long-term 
enriched environment 
BDNF – a notorious gene found to be induced upon EE 
Multiple studies have linked beneficial effects of voluntary exercise and enriched 
environment with gene expression changes in specific brain areas (Tong et al., 
2001;Barak et al., 2013;Hu et al., 2013). One candidate gene found to be upregulated 
upon enriched living conditions in both WT and Tg4-42het mice in the present study is 
the brain derived neurotrophic factor (BDNF) (Figure 18D) (Hüttenrauch et al., 2016). 
BDNF belongs to a small family of secreted trophic proteins including nerve growth 
factor (NGF), neurotrophin 3 (NT-3) and neurotrophin 4 (NT-4) and regulates neural 
development, synaptogenesis and neuronal plasticity in the brain (McAllister et al., 
1999;Huang and Reichardt, 2001;Poo, 2001). Consistent with the present study, 
numerous former reports have shown that both environmental enrichment and long-
term physical activity increase BDNF expression levels (Neeper et al., 1996;Ickes et al., 
2000;Rossi et al., 2006). As an induction of BDNF is often accompanied by an enhanced 
cognitive performance, it is suggestive that the beneficial effects of exercise on memory 
function depend on BDNF. Several lines of evidence link BDNF with improved learning 
and memory. For example, mutations or region-specific manipulations of BDNF and its 
receptors have been shown to cause deficits in spatial, as well as object recognition 
memory (Linnarsson et al., 1997;Mizuno et al., 2000;Saarelainen et al., 2000;Furini et 
al., 2010). In addition, BDNF appears to play a substantial role during the late phase of 
LTP in the CA1 region of the hippocampus (Pang and Lu, 2004) and its overexpression 
causes increased dendrite complexities in the CA1 region and dentate gyrus (Tolwani 
et al., 2002;Alonso et al., 2004). Hence, it is tempting to speculate that the exercise-
induced cognitive improvement in WT and Tg4-42het mice is at least partially 
dependent on BDNF function. Another factor supporting the notion of BDNF as a 
trigger for the beneficial effects of EE on Tg4-42 pathology is its neuroprotective 




AD model upon BDNF gene delivery to the entorhinal cortex (Nagahara et al., 2013). 
This neuroprotection was achieved without detectably altering Aβ deposition, which is 
in good agreement with the findings of the current thesis and demonstrates that BDNF-
dependent neuronal survival is not per se dependent on changes in amyloid pathology.   
 
Molecular chaperones and their attempt to protect neurons from damage 
A striking number of transcripts found to be upregulated in physically active Tg4-42het 
mice belong to the family of heat shock proteins (Hsps) (Figure 18D) (Hüttenrauch et 
al., 2016). It has been shown in numerous studies that the induction of Hsps can be 
triggered by environmental stress conditions such as exercise in both humans and 
rodents (Lancaster et al., 2004;Nickerson et al., 2005;Ding et al., 2006). The 
fundamental role of Hsps is to protect cells from damage by refolding or degrading 
misfolded proteins and therewith maintaining the functionality of the proteome 
(Wilhelmus et al., 2007). Due to the tendency of Aβ to misfold into toxic oligomers, the 
role of Hsps in AD and especially their interaction with Aβ, has gained particular 
interest. Magrané and colleagues have shown that an overexpression of Hsp70 protects 
primary neuronal cultures from toxic effects of intracellular Aβ42 accumulation 
(Magrane et al., 2004). Furthermore, Hsp70/40 and Hsp90 have been described to 
block Aβ self-assembly at substochioemetric concentrations in vitro, mainly by causing 
structural changes in Aβ oligomers (Evans et al., 2006). A similar function has been 
proposed for the HSP40-homolog DNAJB6, which modulated Aβ42 aggregation in vitro 
by binding to Aβ fibrils thereby inhibiting their elongation and growth (Mansson et al., 
2014). The strongest upregulated gene in Tg4-42het EE mice was αB-Crystallin, a small 
heat shock protein being predominantly localized in astrocytes and oligodendrocytes, 
as well as around neuron surrounding plaques (Shinohara et al., 1993;Renkawek et al., 
1994). αB-Crystallin has been shown to co-localize with Aβ in vivo (Yoo et al., 2001). In 
vitro, the co-chaperone binds to Aβ42 fibrils along their entire length thereby inhibiting 
their elongation (Shammas et al., 2011). Moreover, αB-Crystallin has been described to 
have a protective effect on Aβ-induced cytotoxicity (Dehle et al., 2010). Taken together, 
it can be assumed that the chaperones found to be upregulated in Tg4-42het mice in the 
current analysis interact with Aβ4-42 in a similar fashion. Thereby, they might induce 
conformational changes resulting in a reduced neurotoxicity, as shown by a diminished 




A subset of Hsps found to be upregulated upon enriched environment in Tg4-42het mice 
could also been observed in active WT animals (Figure 18E), indicating a common 
pathway associated with long-term cognitive and physical stimulation, which is 
independent of the genotype. This collective of genes, implying CRYAB, HSPH1 and 
HSPA1B, can be collated to the “protein processing in the endoplasmic reticulum” 
pathway (Figure 18F). This pathway is involved in endoplasmic reticulum (ER) quality 
control leading to the disposal of misfolded proteins and their degradation through the 
proteasome and is part of a cellular stress response (Liu and Chang, 2008). The 
induction of growth factors like BDNF, as well as the upregulation of genes that encode 
cytoprotective proteins such as heat-shock proteins, is carried out by neurons as a 
consequence of mild stressors like exercise or caloric restriction. This might represent 
a synergistically acting “pre-conditioning” phenomenon needed to increase cellular 
abilities to resist more severe stress, including accumulation of misfolded amyloid 
peptides (Mattson et al., 2004). 
 
Necdin – a new candidate gene implicated in the beneficial effects of EE? 
The gene showing the strongest downregulation in Tg4-42het mice upon lifelong 
exercise compared to standard housed animals was Necdin (NDN) (Figure 19), a 
protein implicated in Prader-Willi syndrome (Jay et al., 1997). NDN is expressed in 
postmitotic neurons and it was shown that Ndn-/- mice display an improved spatial 
learning and memory performance in the MWM task (Muscatelli et al., 2000). As NDN 
expression levels increase in Tg4-42het SH mice compared to wild-type controls and 
drop again to baseline upon enrichment (Figure 19), it is suggestive that Ndn plays a 
role in the improved phenotype of exercised Tg4-42het mice. However, further studies 
are warranted to explore the precise mechanistic link between Necdin and memory 
performance. 
In summary, EE training appears to upregulate genes involved in pathways yielding to 
neuroprotective events. As these genes control multiple cellular processes, their 
analysis at the system level would be the next suitable step to gain further knowledge 
about the molecular substantiation of EE. It is indisputable that the beneficial effects 
seen upon cognitive and physical enrichment in rodents are a product of multiple 




4.1.1.7 Conclusions of Project I, Part I: 
Based on the results of the current work: 
- Long-term physical activity exerts a preventive effect on CA1 neuron loss 
induced by intraneuronal Aβ4-42 expression in the Tg4-42 AD mouse model. 
- The diminished neuronal cell death is accompanied by an improved motor 
performance and a complete memory recovery in Tg4-42het mice. 
- The observed beneficial effects of cognitively and physically stimulating living 
conditions in Tg4-42het mice are irrespective of a change in Aβ4-42 total brain 
levels and neurogenesis rates. 
- Long-term enriched living induces genes involved in pathways yielding to 
neuroprotective events. 
4.1.2 Part II: Lifelong environmental enrichment in combination with 
voluntary exercise has limited effects on the pathology of 5XFAD mice 
4.1.2.1 Long-term enriched living conditions have a limited effect on the 
physiological status and the sensory-motor phenotype of 5XFAD mice 
APP transgenic mouse models frequently exhibit a premature death phenotype caused 
by heavy amyloid deposition and subsequent cerebral vascular damage (Calhoun et al., 
1999;Van Dorpe et al., 2000). As reported in previous studies, a reduced survival rate 
of 5XFAD SH mice could be observed in course of the current thesis (Heraud et al., 
2014). However, this phenotype could not be attenuated upon enriched conditions 
(Figure 21A).  
5XFAD mice display a reduced body weight starting with 9 months of age. The weight 
loss is aggravated over time, reaching a loss of 25% in comparison to WT littermates 
by the age of 12 months (Jawhar et al., 2012). Prolonged living in an enriched 
environment had no influence on the drastically reduced body weight of 5XFAD mice 
(Figure 21B). Therefore, no improvement in general health condition could be 
achieved by long-term physical and cognitive stimulation.   
12-month-old 5XFAD mice are characterized by prominent amyloid plaque pathology 
in motor-related brain areas. Furthermore, accumulation of intraneuronal A in motor 




formation of axonal spheroids (Jawhar et al., 2012). Accordingly, severe sensory-motor 
impairments in the string suspension task and beam walking have been reported for 
5XFAD mice starting with 9 months of age (Jawhar et al., 2012). This phenotype could 
not be rescued due to prolonged cognitive and physical stimulation (Figure 21C, D). 
However, as shown in previous studies, 5XFAD mice exhibit an abnormal rotarod 
performance with 12 months of age, which was completely rescued upon enriched 
living conditions (Figure 21E) (Shukla et al., 2013). As no amelioration in other motor 
tasks like string suspension and balance beam could be detected, the significant rescue 
of the rotarod performance points to a better overall motor coordination. This is likely 
based on a continuous interaction with the enriched environment, but not general 
muscular strength. Hence, the improved rotarod performance confirms the validity of 
the enrichment paradigm in the present study.  
4.1.2.2 Enriched living conditions do not alter the behavioural phenotype of 
5XFAD mice 
Anxiety, disinhibition and depression belong to the neuropsychological changes that 
frequently accompany disease progression of AD patients (Mega et al., 1996;Lyketsos 
and Olin, 2002). Anxiety-related behaviour in mice can be studied using the elevated 
plus maze task. An increased time spent in open arms reflects reduced anxiety levels 
while more time spent in the closed arms is an indication of increased anxiety (Walf 
and Frye, 2007). Mechanistically, changes in the circuitries of the limbic system, 
susceptible to A accumulation, seem to be involved in altered elevated plus maze 
behaviour (Lalonde et al., 2012). At the age of 6 months, 5XFAD mice demonstrate 
reduced anxiety levels, which further decrease in an age-dependent manner (Jawhar 
et al., 2012). Environmental enrichment in combination with exercise was not capable 
to compensate anxiety-related behavioural deficits (Figure 22A). Literature on the 
effect of EE on this phenotypic trait in AD mouse models is scarce. Therefore, the data 
gathered in the current thesis can only be confronted to a limited number of 
comparable studies. The present finding is consistent with recent data from our group 
demonstrating no changes in low levels of anxiety-like behaviour in the APP/PS1KI 
mouse model, which was unchanged after 4 months of EE (Cotel et al., 2012). In 




phenotype in Tg2576 mice when EE occurred early in the animal’s lifespan (Verret et 
al., 2013).  
With 6 months of age, 5XFAD mice start to suffer from working memory deficits which 
further increase in an age-dependent manner (Oakley et al., 2006;Jawhar et al., 2012). 
To evaluate working memory deficits in rodents, spontaneous alternation tasks like the 
Y-, T- or cross-maze are used. These tasks are sensitive to lesions in the prefrontal 
cortex and hippocampus, making them suitable for AD pathology relevant 
impairments. Many studies on the effect of enriched environment in AD mouse models 
reported clearly improved performances in cognitive tests (Parachikova et al., 
2008;Dao et al., 2013;Wang et al., 2013). However, no improvement in working 
memory performance upon enriched living conditions in 5XFAD mice could be 
assessed in course of this thesis (Figure 22C). This again is in good agreement with 
results from a study previously performed in our group, where standard- and enriched 
housed APP/PS1KI mice showed equally bad performances in the Y-maze task 
compared to age-matched WT controls (Cotel et al., 2012). It is worth mentioning that 
in most of the environmental enrichment studies, cognitive performances are assessed 
using the MWM test, which allows to analyse both spatial working, as well as reference 
memory capacities. Unfortunately, we were unable to perform the MWM test with 12-
month-old 5XFAD mice, due to their massive impairments in swimming capability and 
their drastic motor phenotype at that age.  
In summary, enriched housing combining cognitive enhancement and physical activity 
did not ameliorate the behavioural deficits seen in 12-month-old 5XFAD mice. 
4.1.2.3 Standard- and enriched housed 5XFAD mice display similar levels of 
amyloid pathology 
No differences in amyloid plaque pathology due to enriched environment living 
conditions were found between 5XFAD SH and EE mice in course of the present study 
(Figure 23A, B). Previous analyses on the influence of EE on extracellular plaque 
pathology in AD mouse models are inconsistent. Some investigations are in accordance 
with our observations reporting no effect of enriched living conditions on amyloid 
deposition (Arendash et al., 2004;Wolf et al., 2006;Parachikova et al., 2008;Cotel et al., 
2012), while others found a reduction (Mirochnic et al., 2009;Ke et al., 2011;Liu et al., 




harbour a robust plaque pathology which is preceded by intraneuronal accumulation 
of Aβ starting at the age of 6 weeks. With 2 months of age, first plaques appear in deep 
layers of the cortex and in the subiculum. During aging, amyloid deposition progresses 
and becomes present in the entire cortex, subiculum and hippocampus. To a lesser 
extent, plaques also become apparent in thalamus, olfactory bulb and brainstem 
(Oakley et al., 2006). The EE starting time point of the current study was chosen in the 
presymptomatic phase as there are studies showing that only when access to running 
wheels is given prior to disease onset, reduced plaque pathology can be observed 
(Adlard et al., 2005;Richter et al., 2008). However, no differences in Aβ plaque load 
were revealed in cortex, hippocampus, subiculum or thalamus between enriched and 
sedentary 5XFAD mice at 12 months of age. Notably, it has been reported earlier that 
there is a rapid increase in amyloid pathology in 5XFAD mice until the age of 6 months, 
which subsequently becomes less severe and reaches a certain plateau level at the age 
of 10 to 14 months, depending on the sex of the animal (Bhattacharya et al., 
2014;Richard et al., 2015). Therefore, one cannot exclude that the enrichment 
paradigm leads to a certain delay in plaque deposition at earlier time points during 
disease progression, which, by the end of the treatment period is not visible anymore 
due to the reached plateau level of amyloid plaques. To test this hypothesis, plaque 
pathology could be analysed at earlier ages during the EE treatment period in a time-
dependent manner.  
Beauquis and colleagues recently reported lowered Aβ1-40 and Aβ1-42 levels upon 
enriched housing while the number and size of Aβ plaques did not change (Beauquis et 
al., 2013). These observations were further extended by Rao and colleagues, showing 
significantly decreased levels of soluble and insoluble Aβ1-40 and Aβ1-42 levels in both 
cortex and hippocampus upon voluntary exercise (Rao et al., 2015). There are multiple 
mechanisms described which could possibly be involved in lowering Aβ levels due to 
exercise and thereby improving cognitive abilities. For example, Rao et al. found 
reduced protein levels of β-secretase (BACE1) in active APP/PSEN mice compared to 
sedentary mice, which could be one mechanism explaining reduced Aβ levels. 
Moreover, increased levels of Aβ-degrading enzymes (ADEs) like neprilysin (NEP) and 
insulin-degrading enzyme (IDE) following EE paradigms have been reported, 
supposably leading to an increased degradation of Aβ peptides (Lazarov et al., 




insoluble Aβ1-42 levels could be detected (Figure 23C, D). Accordingly, BACE1, NEP and 
IDE levels were unchanged between active and inactive 5XFAD mice (Figure 25).  
Neuroinflammation, characterized by activation of astrocytes and microglia, is one of 
the major hallmarks of AD and develops concomitantly with amyloid deposition in the 
5XFAD mouse model (Oakley et al., 2006). Many reports describe a decline in 
inflammatory markers like GFAP upon voluntary exercise accompanied by reduced Aβ 
levels (Nichol et al., 2007;Nichol et al., 2009;Kang et al., 2013;Souza et al., 2013). 
Corresponding to the comparable amyloid phenotype seen in the current study, our 
findings show no changes in the inflammatory status between enriched and sedentary 
5XFAD mice in the analysed brain areas cortex, hippocampus and thalamus (Figure 
24).  
4.1.2.4 Induction of neuroprotective genes in physically active 5XFAD mice 
As already mentioned earlier, numerous reports have shown elevated expression 
levels of the neurotrophic factor BDNF following voluntary exercise in both humans 
and rodents. Accordingly, active 5XFAD mice displayed significantly increased BDNF 
mRNA levels when compared to sedentary controls, which further indicates a 
successful EE protocol (Figure 25). An induction of BDNF due to physical activity is 
often paralleled by an enhanced cognitive performance, which supposes this 
neurotrophic factor as a key player in this process. However, in the present study, 
increased BDNF levels in 5XFAD EE mice were not associated with beneficial effects on 
cognitive impairment. Congruently, Liu and colleagues even found an exercise induced 
decrease of BDNF mRNA levels in APP/PS1 mice paralleled by a better cognitive 
performance and LTP (Liu et al., 2011). Next to BDNF, mRNA expression analyses 
revealed that members of the heat-shock protein family were upregulated in enriched 
housed 5XFAD mice compared to standard housed controls (Figure 25). In contrast to 
WT and Tg4-42het mice, the induction of HSPs in 5XFAD was not accompanied by 
beneficial effects on the cognitive performance. This could be explained by the fact that 
the 5XFAD model represents a robust and aggressive mouse model of AD pathology, 
which is based on multiple mutations in AD-related genes. Even though 
neuroprotective genes like BDNF and HSPs are being induced upon exercise, the 





4.1.2.5 Conclusions of Project I, Part II: 
Based on the results of the current work: 
- Long-term environmental enrichment has limited effects on the general health 
condition and sensory-motor phenotype of 5XFAD mice. 
- Anxiety-related behavioural deficits and working memory impairments are not 
ameliorated due to physically and cognitively stimulating living conditions. 
- Enriched-housed 5XFAD mice do not display diminished amyloid pathology and 
A1-42 levels. 
- The inflammatory response in brains of 5XFAD mice is not declined upon 
prolonged EE. 
- Long-term enriched living induces genes involved in pathways yielding to 
neuroprotective events, however, without an effect on the pathology. 
 
4.2 Project II: Neprilysin deficiency alters the neuropathological 
and behavioural phenotype in the 5XFAD model of Alzheimer’s 
disease 
5XFAD mice are characterized by amyloid plaque formation as early as two months of 
age, which is preceded by intraneuronal Aβ accumulation. Next to Aβ1-40, Aβ1-42 levels 
are tremendously increased due to the co-expression of five familial AD mutations in 
this double transgenic APP/PS1 mouse model (Oakley et al., 2006;Jawhar et al., 2012). 
5XFAD mice therefore display a valuable tool recapitulating many AD-related 
phenotypes and represent a suitable model to analyse possible therapeutic strategies. 
During the last decades, numerous therapeutic approaches that target Aβ have been 
developed with the ultimate goal to diminish its toxic action in brains of AD patients. 
These approaches include the prevention of Aβ oligomerization, an improved 
clearance of the peptide through the blood brain barrier, the prevention or reduction 
of Aβ production, as well as enhanced degradation (Bates et al., 2009). A slowdown of 
Aβ degradation by Aβ-degrading enzymes (ADEs) is the major presumed cause of Aβ 
accumulation in sporadic AD cases (Iwata et al., 2005). Among a variety of ADEs, 
neprilysin (NEP) is considered to be one of the most important physiological enzymes 




the ability of NEP to cleave Aβ monomers and oligomers at several cleavage sites 
(Wang et al., 2006;Miners et al., 2011). A role of NEP has also been shown in vivo. A 
knock-out of the metalloprotease led to enhanced levels of soluble and oligomeric Aβ 
and subsequent impairments in synaptic plasticity as well as cognitive abnormalities 
in APP transgenic and WT mice (Huang et al., 2006;Madani et al., 2006). The primary 
objective of this part of the study was to evaluate the in vivo effect of NEP level 
reduction on the neuropathological and behavioural phenotype in young and aged 
5XFAD mice. Therefore, the 5XFAD/NEP+/- mouse model was generated by crossing 
NEP-/- mice with 5XFAD mice (Lu et al., 1995;Oakley et al., 2006). It could be shown 
that young 5XFAD mice per se display strongly reduced NEP levels when compared to 
WT animals. In 6-month-old 5XFAD mice, reduced NEP levels were still present, albeit 
being not that distinct (Figure 26A, B) (Hüttenrauch et al., 2015). These results confirm 
recent findings from Ohno and colleagues, who observed reduced NEP levels in 12-
month-old 5XFAD mice (Devi and Ohno, 2015). In accordance, NEP levels have been 
shown to decrease during normal aging, as well as during disease progression in 
human AD brains, further substantiating its crucial role during AD development (Iwata 
et al., 2002;Caccamo et al., 2005;Wang et al., 2010). In young and aged 5XFAD mice, a 
heterozygous NEP knock-out led to a further decrease in the NEP mRNA expression 
level, reaching only 7 or 8.5% of WT mice levels, respectively. A successful NEP 
depletion in 5XFAD/NEP+/- mice could also been proven on the protein level by 
performing immunohistochemical stainings (Figure 26C).     
Intriguingly, 5XFAD/NEP+/- mice displayed deficits in spatial working memory at 6 
months of age when compared to 5XFAD littermates (Figure 27) (Hüttenrauch et al., 
2015). This is consistent with recently published data showing an impaired 
performance in the MWM task in a mouse model of amyloidosis with heterozygous NEP 
deficiency (Mohajeri and Wolfer, 2009). Moreover, Huang et al. observed behavioural 
deficits in the Y-maze and MWM in APP23 mice on a homozygous NEP knock-out 
background (Huang et al., 2006). Therefore, the inefficient removal of Aβ from the 
brain due to NEP depletion in the current study led to a diminished performance of 
5XFAD/NEP+/- mice in hippocampus-dependent cognitive tasks, further confirming 
previous results showing that a downregulation of NEP contributes to the 




In line with the altered memory performance, immunohistochemical stainings and 
subsequent quantifications revealed a significantly increased Aβ plaque load in the 
dentate gyrus, subiculum and spinal cord of 6-month-old 5XFAD/NEP+/- mice when 
compared to 5XFAD controls (Figure 28A, B). Previous studies in J9 mice on a hemi- or 
homozygous NEP deficient background corroborate the findings of the current thesis. 
NEP depletion markedly increased the hippocampal amyloid plaque burden in this APP 
transgenic model (Farris et al., 2007). The fact that Thioflavin S-positive deposits were 
unchanged in all analysed brain areas between 5XFAD and 5XFAD/NEP+/- mice, 
supports the hypothesis that NEP mainly degrades soluble Aβ peptides (Figure 28C) 
(Hüttenrauch et al., 2015). A related observation was reported in hAPP transgenic mice 
which were crossed with neprilysin transgenic mice. NEP overexpression in these mice 
reduced soluble Aβ levels but had no impact on amyloid plaque load (Meilandt et al., 
2009). This is in line with higher Aβ1-42 levels in TBS-soluble brain fractions in the 
presence of unchanged SDS-soluble Aβ levels in 5XFAD/NEP+/- mice in the current 
study (Figure 28E, F).  It is noteworthy that the extracellular Aβ plaque load in 5XFAD 
and 5XFAD/NEP+/- mice was unchanged in cortex and thalamus. However, the higher 
abundance of amyloid plaques in the dentate gyrus and subiculum of 5XFAD/NEP+/- 
animals correlates well with the previously demonstrated intense NEP 
immunoreactivity in the hippocampal area of WT mice, suggesting that NEP deficiency 
has a stronger impact in this brain region than in regions like the cortex or thalamus 
(Fukami et al., 2002). 
Surprisingly, at young ages 5XFAD mice displayed a 70% higher extracellular plaque 
load when compared to age-matched 5XFAD/NEP+/- mice (Figure 30). Amyloid 
deposition is always accompanied by an inflammatory response. Accordingly, 2.5-
month-old 5XFAD mice showed increased GFAP mRNA expression levels in in 
comparison to all other experimental groups, while at older ages, GFAP levels were 
equally increased in 5XFAD and 5XFAD/NEP+/- mice in comparison to healthy controls 
(Figure 29). This finding is in accordance with significantly increased insulin-
degrading enzyme (IDE) mRNA levels in young 5XFAD mice when compared to WT and 
5XFAD/NEP+/- mice. IDE is another putative protease that has been shown to degrade 
Aβ peptides in vivo (Eckman and Eckman, 2005) and is known to be upregulated in 
response to increased Aβ production (Vepsäläinen et al., 2008). In older 5XFAD/NEP+/- 




Intriguingly, expression analysis of the close NEP homologue endothelin-converting 
enzyme 1 (ECE1) revealed that this ADE is significantly increased in NEP-deficient mice 
compared to 5XFAD mice in young animals (Figure 31). ECE1 has been shown to 
degrade Aβ within intracellular compartments, which ultimately leads to a reduced 
secretion of the peptide and reduced extracellular accumulation (Eckman et al., 2001).  
As recently detected in SH-SY5Y cells, ECEs are capable of degrading at least two 
distinct pools of Aβ. One is intended for secretion, while the other is being produced 
and degraded within endosomes and lysosomes (Pacheco-Quinto and Eckman, 2013).  
The increased ECE1 levels in young 5XFAD/NEP+/- mice correlate well with the 
strongly reduced extracellular Aβ signal compared to 5XFAD animals and suggest a 
reciprocal effect between ECE and NEP activities in A degradation (Hüttenrauch et al., 
2015). This is also supported by the reported expression profile of ECE1 in pyramidal 
neurons of cortical layer V (Pacheco-Quinto et al., 2013), the same layer that shows 
prominent intracellular accumulation of A peptides in 5XFAD mice (Jawhar et al., 
2012). The results of the current thesis provide in vivo evidence for a mutual regulation 
between the two ADEs NEP and ECE1, further supported by the observation that NEP+/- 
and NEP-/- mice display elevated ECE1 expression levels as well, with NEP-/- animals 
showing the highest levels of ECE1 at this early time point. However, it warrants 
further investigation to delineate why ECE1 levels are normalized at older ages 
although NEP levels are still drastically reduced in hemi- and homozygous NEP-
deficient mice.  
4.2.1 Conclusions of Project II: 
Based on the results of the current work: 
- 5XFAD mice display strongly reduced neprilysin levels compared to WT mice. 
- Neprilysin deficiency leads to spatial working memory deficits in 6-month-old 
5XFAD mice. 
- Aged 5XFAD/NEP+/- mice demonstrate region-specific increases in extracellular 
Aβ deposition, overall increased levels of soluble Aβ1-42 and an elevated 
astrocytosis in all studied brain areas. 
- In young 5XFAD/NEP+/- mice, extracellular Aβ plaque pathology is delayed 




- 2.5-month-old 5XFAD/NEP+/-, NEP+/- and NEP-/- display elevated levels of ECE1, 
suggesting a compensatory upregulation upon NEP depletion.   
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5 SUMMARY & CONCLUSIONS 
There is substantial evidence for a protective role of physical and cognitive activity on 
the risk and progression of Alzheimer’s disease (AD). Although numerous studies in 
rodent models have explored beneficial effects of an enriched environment (EE) 
combined with voluntary exercise on AD pathology, it is difficult to draw clear-cut 
conclusions. Confounding variables are variations in study design regarding the type 
of enrichment, different durations and extent of physical activity, different ages at 
which animals are exposed to EE, as well as differences in the used AD models.  Most 
studies were conducted in models overexpressing mutant forms of human APP, 
presinilin 1/2, or a combination of both. Even though all of these AD models develop 
typical pathological hallmarks of AD, it is hard to translate findings to the situation of 
sporadic AD patients, which neither possess any mutations nor APP overexpression. 
Furthermore, despite massive research, relatively little is known about the effect of 
physical activity on neurodegenerative processes in the hippocampus, a brain region 
being one of the first and most severely affected during AD progression. This is likely 
due to the fact that only a small number of AD mouse models display a reliable 
hippocampal neuron loss. 
The goal of the first part of the present work was to investigate the effect of long-term 
enriched environment, combining cognitive enhancement and physical activity, on the 
newly-developed Tg4-42 mouse model. This model overexpresses Aβ4-42 without any 
mutations and develops an age-dependent hippocampal neuron loss associated with a 
severe memory decline. Tg4-42 mice therefore represent a valid AD mouse model 
which reflects the key features of sporadic AD. By using unbiased, design-based 
stereology, it was demonstrated that long-term physical stimulation exerts a 
preventive effect on hippocampal CA1 neuron loss induced by intraneuronal Aβ4-42 
expression in Tg4-42het and Tg4-42hom mice. Behavioural analyses revealed that the 
diminished neuronal cell death was accompanied by an improved motor performance 
and a complete memory recovery. Furthermore, lifelong exercise induced gene 
expression pathways yielding to neuroprotective events. These effects were 
irrespective of total Aβ4-42 brain levels and increased neurogenesis rates. Taken 
together, the present study provides evidence for the first time that enhanced cognitive 
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and physical activity counteracts hippocampal neuron loss and behavioural deficits in 
a transgenic AD mouse model without mutations and APP overexpression. 
Furthermore, we found evidence that changes in gene-expression programs play a 
substantial role in the observed effects. These results underscore the relevance of a 
challenging lifestyle in combination with regular exercise as a potential strategy in the 
prevention of sporadic AD.   
In contrast to Tg4-42 mice, 5XFAD mice represent a conventional model with an early, 
robust and aggressive AD pathology. Although vast literature is reporting about 
beneficial effects of EE on the pathology of familial AD models, no study investigated 
the widely-used 5XFAD model so far. In the present work, despite of partial benefits in 
motor performance, no effect on anxiety levels, working memory performance, plaque 
deposition, Aβ1-42 levels or inflammatory status could be observed upon prolonged 
enriched living conditions. Therefore, a lifelong cognitive and physical stimulation has 
no therapeutic benefit on the Alzheimer-like pathophysiology of 5XFAD mice.  
Taken together, the results of the first part of this thesis support that physical activity 
and environmental enrichment can counteract disease progression in the Tg4-42 
mouse model, which likely represents a model more suitable for the most common 
sporadic form of AD. In contrast, the 5XFAD model represents a robust and aggressive 
model of familial AD incorporating five different mutations. The disease phenotype of 
5XFAD mice cannot be counteracted efficiently by a rather mild intervention like EE 
and voluntary exercise. 
 
The deposition of Aβ in form of soluble oligomers, insoluble fibrils or neuritic plaques 
is one of the major hallmarks of AD. In familial AD cases, an enhanced production of Aβ 
caused by mutations in genes encoding APP and presinilins leads to an enhanced 
accumulation of the peptide. In sporadic AD cases, however, the cause of increased Aβ 
accumulation is likely due to decelerated degradation. The metalloprotease neprilysin 
(NEP) is one of the major Aβ-degrading enzymes (ADEs) as shown by numerous in 
vitro, in vivo and reverse genetic studies. This second part of the current thesis aimed 
on gaining deeper knowledge about the role of neprilysin during the progression of AD. 
Therefore, 5XFAD mice were crossed with homozygous NEP knock-out mice (NEP-/-). 
It was shown that 5XFAD mice per se exhibit reduced NEP levels when compared to 
WT mice. 5XFAD/NEP+/- animals displayed an even stronger NEP level reduction 
resulting in an impaired spatial working memory. Furthermore, hemizygous NEP 
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deficiency led to region-specific increases in extracellular amyloid deposition, overall 
increased levels of Aβ42 and an enhanced inflammatory response in all studied brain 
areas. In contrast, young 5XFAD/NEP+/- mice showed cortical Aβ plaque pathology to a 
much lesser extent than age-matched 5XFAD animals. This finding was accompanied 
by elevated levels of endothelin-converting enzyme 1 (ECE1) in young 5XFAD/NEP+/-, 
NEP+/- and NEP-/- mice, suggesting a mutual regulation of ECE1 and NEP in 2.5-month-
old animals. In total, these observations support previous in vivo data indicating that 
NEP is one of the main Aβ-degrading peptidases. Hence, the current findings provide 
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